Clinical exercise testing with reference to lung diseases : indications, standardization and interpretation strategies by Roca, J. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Eur Respir J 1997; 10: 2 6 6 2 -2 6 8 9  
Printed in UK - all rights reserved
Copyright © E R S  Journals Ltd 1997  
European Respiratory Journal 
ISSN 0903 - 1936
ERS TASK FORCE
Clinical exercise testing with reference to lung diseases: 
indications, standardization and interpretation strategies
ERS Task Force on Standardization of Clinical Exercise Testing
Members of the Task Force: J. Roca and B.J. Whipp (co-chairmen), A.G.N. Agusti, S.D. Anderson, 
R. Casaburi, J.E. Cotes, C.F. Donner, M. Estenne, H. Folgering, T.W. Higenbottam, K.J. Killian, 
P. Paiange, A. Patessio, C. Prefaut, R. Sergysels, P.D. Wagner and I. Weisman
CONTENTS
Responses to exercise in lung disease........................................................................... . .  2663 Other tests:
Pulmonary gas exchange...................... .................. .  2663 Constant work rate exercise testing........................ 2669
Ventilation ............................................................ .... . 2663 Assessment of exercise-induced bronchoconstriction 2670
Arterial blood gases ............................................... 2665 Equipment and quality-control programme.......... 2671
Cardiovascular response ......*................................. 2665 Choice of ergometers.............................................. 2671
Limits to exercise.................................................. 2666 Gas exchange measurements................................... 2672
Indications.......................................................... . .  2666 The lactate threshold.............................................. 2673
Assessing exercise tolerance and potential limiting factors Exercise testing measurement systems.................... 2673
, 2667 Quality control programme..................................... 2615
Assessment of impairment in chronic lung diseases. 2667 Personnel and testing procedures......................... 2676
Preoperative assessment ......................................... . 2667 Personnel qualifications.......................................... 2676
Rehabilitation programmes: patient assessment and Patient preparation.................................................. 2676
exercise prescription.................... ........................... .. 2668 Safety precautions................................................... 2677
Assessment of impairment-disability....................... .. 2668 Interpretative strategies........................................ 2678
Lung, heart-lung transplantation................................ 2668 General guidelines.................................................. 2678
Protocols.................................................................. 2668 Reference values..................................................... 2680
Standard clinical exercise protocol: incremental test.. 2668 Appendix............................................................ 2681
Cardiopulmonary exercise testing (CPET) is a unique 
tool to assess the limits and mechanisms of exercise 
tolerance. It also provides indices of the functional 
reserves of the organ systems involved in the exercise 
response, with inferences for system limitation at peak 
exercise. Moreover, CPET is useful for establishing the 
profiles and adequacy of the responses of the systems 
at submaximal exercise. The present document is essen­
tially focused on clinical problems commonly faced in 
the study of patients with pulmonary diseases. Physiologi­
cal changes of the respiratory system during exercise, 
however, should only be considered as part of a co-ordi- 
nated sequence of oxygen and carbon dioxide transfer 
processes between the atmosphere and the mitochon­
dria to meet the increased energy demand of the skele­
tal muscle. Consequently, even in the analysis of patients 
with well-identified pulmonary disease, an integrative 
approach to CPET [1, 2] is required.
CPET is an area of growing interest in pulmonary 
medicine for three major reasons: 1) its large potential 
clinical applicability (see section on Indications); 2) the 
essentially noninvasive nature of the testing; and 3) pro­
vision of information that cannot be obtained through
conventional lung function testing performed at rest [3- 
9]. During the past few years, two factors have con­
tributed to the current level of interest in CPET in pul­
monary medicine. First, substantial progress has been 
made in clarifying fundamental concepts of exercise 
physiology (e.g., factors limiting maximal oxygen up­
take, lactate threshold) which have historically been 
the focus of controversy. Secondly, major technologi­
cal improvements have facilitated data collection, sub­
ject monitoring during the test and subsequent formatting 
and analysis of the results. Nowadays, CPET can be 
considered a primary test in the pulmonary function 
laboratory.
The present European Respiratory Society (ERS) pos­
ition document reflects the views on the topic shared 
by the members of the Task Force. One of the self-impos­
ed goals of the group was to produce a relatively reader- 
friendly document that combined a rigorous conceptual 
approach with practical utility for CPET in a clinical 
setting. The document can be either read as a whole, 
or the first section (Responses to exercise in lung dise­
ase) can be used alone, as a frame of reference to clarify 
specific points of the document. Definitions, abbreviations,
This position document of the European Respiratory Society was officially adopted by the ERS Executive Committee on March 1, 1997.
The Task Force on Standardization of Clinical Exercise Testing was endorsed by the Clinical Physiology Assembly and the Clinical Assembly 
of the ERS.
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information content and units of the recommended vari­
ables are presented in the Appendix. Finally, as a group, 
the Task Force acknowledges that the introduction of
SI units has represented a valuable effort not only to 
provide a coherent system of units, but also to ensure 
that units are uniform in concept and style. Unfortuna­
tely, the use of SI is still insufficiently widespread in 
clinical exercise testing. In order to avoid nomenclature 
that can be unfamiliar to many readers, we decided to 
use traditional units in the text but also provide the 
equivalences between the two systems of units in the 
Appendix.
Responses to exercise in lung disease
Exercise intolerance results when a subject is unable 
to sustain a required work rate (WR) sufficiently long 
for the successful completion of the task. The cause, 
most commonly, is an oxygen demand that exceeds the 
maximal oxygen conductance capability of the oxygen 
transport chain; the consequence is a perception of limb 
fatigue, breathlessness or even, in some conditions, frank 
pain. Subjects with lung disease often experience ex­
ercise intolerance at extremely low work rates. There 
are many kinds of lung disease, however, and in any 
one patient the structural and functional severity of the 
disease may range from the barely discernible to the 
very severe. As a result, responses to exercise in patients 
with lung disease do not show the tight stereotypical 
pattern of normal subjects.
The appropriateness of the integrated systemic respon­
ses are perhaps best studied utilizing incremental ex­
ercise testing either as a ramp or small WR increments 
each of short duration. This provides a convenient means 
of: 1) determining whether the magnitude and pattern 
of response of particular variables is normal with respect 
to other variables or to WR; 2) establishing a subject's 
limiting or maximum attainable value for physiological 
variables of interest; and 3) establishing exercise inten­
sity domains, such as the transition between moderate 
and heavy intensity exercise. It is important to recog­
nize, in this context, the difference between submaximal 
and maximal exercise levels. In submaximal exercise, 
the components of the oxygen transport pathway can 
provide adequate oxygen and carbon dioxide fluxes 
between the air and the mitochondria. Mitochondrial 
oxidative capacity has not been reached, symptoms are 
usually tolerable and muscle fatigue has not occurred, 
or at least may be insufficient to impair performance 
appreciably. At maximal exercise, symptoms have cau­
sed the patient to stop exercising. At this stage, one or 
more of the following possibilities exist: 1) Limits to 
oxygen transport have been reached and maximal oxy­
gen consumption (V'o2,max) attained; under such condi­
tions, breathing 100% oxygen, for example, could increase 
V’o2,max [10]; 2) Mitochondrial oxidative capacity has 
been reached and again the subject would be conside­
red to be at Vc^max, but adding oxygen would not raise 
oxygen consumption (V'02); 3) Maximal exercise has 
occurred at a level that does not require maximal oxy­
gen transport or maximal oxidative capacity and here 
exercise has been limited by unusually severe symp­
toms. Under these conditions a plateau in oxygen uptake
(Vo2,max) has not been reached and the appropriate term 
is peak rather than maximal V'02.
Pulmonary gas exchange
Oxygen uptake. The peak V'o2 is typically low in patients 
with lung disease [2, 5, 11]. The increment in V‘o2 in 
response to incremental or steady state exercise, how­
ever, occurs in a manner that often cannot be separa­
ted from that of normal subjects. That is, the response 
is linear with a slope (A V'o2/chan.ge in work rate (AWR)) 
for cycle ergometry of approximately 10 mL-nrnr^W*1 
(i.e. within the 95% confidence limits (95% Cl) of 8.5 
and 11.5 for normal subjects) [12], Yet the oxygen cost 
of breathing per unit ventilation is increased in both 
chronic obstructive pulmonary disease (COPD) and in­
terstitial lung disease (ILD). In COPD, airway obstruc­
tion requires more effort to move a given volume of 
air, while in ILD increased elastic recoil requires more 
inspiratory muscle activity. In mild disease these addi­
tional costs can be quite small; in severe disease the 
expected higher Vl02 from the extra cost of breathing 
may be offset by the slower oxygen transport and uti­
lization kinetics (patients also tend to be sedentary) [13].
Carbon dioxide output (V'C02). Because the tissue capa­
citance for carbon dioxide is markedly greater than for 
oxygen, pulmonary carbon dioxide output will initially 
not rise as fast as pulmonary uptake of oxygen, despite 
similar rates of metabolic exchange. For moderate con­
stant work-rate exercise in healthy young subjects, this 
effect prolongs the 30-40 s time constant of metabolic 
V'C02 from the start of exercise (considered to be close­
ly equivalent to that of pulmonary oxygen uptake) to a 
value of 50-60 s for pulmonary carbon dioxide ex­
change [14, 15]. This transient storage effect is exacer­
bated in patients with COPD who have areas of high 
alveolar ventilation/perfusion (V'aIQ 1) ratios. Com­
monly, these regions receive as much as 50% of the 
alveolar ventilation but only 5% or less of the cardiac 
output [16-18]. As a result, the bulk of the V'C02 comes 
from relatively poorly ventilated areas of the lung. This, 
in addition to any overall slowing of the pulmonary 
blood flow, can retard the kinetics of carbon dioxide 
elimination, which is also seen in those pulmonary vas­
cular disease (PVD) patients with high VlAIQX regions.
Ventilation
The appropriateness of the ventilatory response to 
exercise depends not on the actual level of ventilation 
achieved but rather on the extent to which it subserves 
its pulmonary gas exchange and acid-base regulatory 
requirements. The ventilatory response to exercise, how­
ever, is influenced not only by metabolic rate (most 
closely for carbon dioxide) but also by the regulated or 
"set point1’ level of arterial carbon dioxide tension (Ai,C02) 
and the physiological dead-space fraction of the breath. 
Quantitatively, these are represented by the following 
relationship:
V'E = [863*V'C02]/[Pa,C02*(1- Vd/VT)] (1)
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where 863 is the constant which corrects for the dif­
ferent conditions of reporting the gas volumes (for a 
body temperature of 37°C) and also the transformation 
of fractional concentration to partial pressure; V'E is 
minute ventilation in litres per minute; Pa,C02 indicates 
alveolar carbon dioxide tension in millimetres of mer­
cury (usually taken to be equivalent to Pa,C02); and, Vd/ 
VT is the dead space (Vd) expressed as a fraction of the 
tidal volume (Vt).
Minute ventilation (V'E). Lung disease typically in­
creases both ventilation at rest and the ventilatory re­
quirements for a given level of exercise [2,19, 20]. The 
high work of breathing may also lead to respiratory 
muscle fatigue. This may produce limiting symptoms, 
although shortness of breath cannot necessarily be equa­
ted to respiratory muscle fatigue. Resting ventilation 
is usually greater than normal in patients with COPD, 
ILD and pulmonary vascular disease (PVD). This is 
indirectly due to the presence of V'a/Q' inequality pro­
duced by the classical pathological abnormalities of 
emphysema and chronic bronchitis in COPD and by 
fibrosis in ILD [21]. Thus, an abnormal level of venti­
lation is required to maintain normal Pa,co2, even at rest, 
when there is V'AIQ' mismatching. This is especially so 
in emphysematous patients who often show not only 
the expected higher ventilation needed for eucapnia as 
a result of high V'A/ Q' areas, but even higher ventila­
tion as evidenced by low Pa,C02 (i.e. <40 mmHg (5.3 
kPa)). What drives them to hyperventilate remains 
obscure. Other patients with COPD have carbon dioxide 
retention even at rest. The carbon dioxide retention, of 
course, does not necessarily indicate that the V'E is less 
than normal, only that the normal defence of Pa,C02 has 
failed. In ILD and pulmonary vascular disease (PVD) 
there is often considerable hyperventilation even at rest 
[22-24], with Pa,C02 in the 30-35 mmHg (4.0-4.7 kPa) 
range. This can occur even when Pa,02 is at or above 
60 mmHg (8.0 kPa).
Breathing pattern. In patients with chronic lung dis­
eases, the Vt tends to be lower and the respiratory fre­
quency (/R) higher for a given level of V'E [2, 25]. A 
strong linear relationship between peak exercise VT and 
vital capacity (VC) has been shown both in patients 
with COPD and idiopathic pulmonary fibrosis (IPF), 
suggesting that the differences in peak "Vt are mainly due 
to abnormal respiratory mechanics. However, determi­
ning Vr at submaximal exercise is also useful. During 
exercise, normal human subjects increase/R  by decreas­
ing inspiratory time (fl) fractionally less than expira­
tory time (iE). As a result, the ratio of n to total breath 
duration (itot) (the inspiratory duty cycle (tlltm)) in­
creases in normal humans from 0.35-0.40 at rest to
0.50-0.55 during exercise. Patients with ILD show a 
similar type of response. In contrast, patients with severe 
COPD often show no increase in tl/ttot with exercise, 
thus preserving greater time for expiration.
Pulmonary mechanics. Does ventilation during exer­
cise reach mechanical limits in patients with lung dis­
ease? Certainly, flow rates (inspiratory and/or expiratory) 
can be shown to reach the envelope of the resting max­
imal flow volume curve, particularly during expiration
in COPD [26,27] and even in some elderly normal sub­
jects who are physically fit [28]. As this may be expect­
ed to result in abnormal respiratory sensations, this may 
contribute to exercise limitation. However, unless flow 
limitation is occurring through a substantial majority 
of expiration rather than over a small part of the breath, 
there is no capacity to increase lung volume (to advan­
tage airflow) and fk cannot be increased without com­
promising VT, it may well be that total ventilation is 
not at a mechanically defined upper limit, even if a por­
tion of respiratory flow is. Patients with COPD adopt 
two strategies during exercise to increase V 'E when there 
is expiratory flow limitation: 1) end-expiratory lung vol­
ume (EELV) increases [26, 27], in contrast to normal 
humans who show a fall in EELV during exercise [29], 
or in patients with ILD, who do not change EELV sig­
nificantly during exercise [29, 30]; and 2) inspiratory 
flow rate increases with decreased inspiratory time (i.e., 
allowing more time for expiration). Traditionally, "ven­
tilatory limitation" during exercise has been expressed 
by comparing exercise ventilation to the resting maxi­
mal voluntary ventilation (M W ) as an estimate of ven­
tilatory capacity. However, while convenient, M W  is 
not an ideal yardstick of whether a limit to ventilation 
has occurred during exercise. The M W  manoeuvre is 
performed over only 12-15 s at VT and Jk values that 
usually differ from those adopted naturally during ex­
ercise, and also at different end-expiratory/inspiratory 
lung volumes. Another approach to assessing whether 
ventilation during exercise has attained its limiting value 
has been to add carbon dioxide to the inspired gas dur­
ing exercise [17,31]. If ventilation increases in response 
to the added carbon dioxide, then it can be concluded 
that ventilation in the absence of carbon dioxide was 
not mechanically limited. However, failure to increase 
ventilation in response to added carbon dioxide or to 
added external dead space, for example, could be due 
either to mechanical limitation or to insufficient chemo- 
receptor stimulation to increase ventilation in the face 
of other ventilatory constraints. A further approach has 
been to unload the respiratory system, by breathing 21% 
oxygen in helium rather than in air. This usually in­
creases ventilation during maximal exercise in both 
COPD patients [17, 32] and normal subjects [33, 34]. 
However, one is now dealing with a mechanically alter­
ed respiratory system with a reduced work of breath­
ing per unit ventilation. Such a result is not necessarily 
evidence that ventilation while respiring room air was 
mechanically limited.
Respiratory muscle function. There are several reasons 
to suggest that respiratory muscle function during exer­
cise can be a limiting factor in patients with lung dis­
ease. Most prominent among them are: 1) the load to 
the respiratory muscles is increased both in COPD (air­
flow obstruction) and ILD (increased lung elastance);
2) in COPD the diaphragm is at a mechanical disad­
vantage due to dynamic hyperinflation; and 3) hypox- 
aemia during exercise may render respiratory muscles 
prone to fatigue.
Bronchomotor tone response to exercise. The normal 
bronchomotor response to exercise is a mild degree of 
broncliodilation. Patients with exercise-induced asthma
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and some patients with COPD may show exercise-in­
duced bronchoconstriction, but this is most commonly 
a postexercise phenomenon. Exercise testing is, by def­
inition, useful in investigating the mechanisms of ex­
ercise-induced bronchoconstriction.
Arterial blood gases
Many patients with COPD, ILD or PVD are hypox- 
aemic at rest breathing room air at sea level. That is, 
their Pa,02 is below the lower reference limit, i,e 80 
mmHg (10.6 kPa). There is, however, great variability, 
with Pa,02 being within normal limits for age or as low 
as 30-40 mmHg (4.0-5,3 kPa). In COPD, most of the 
patients show mild-to-moderate hypoxaemia 60-70 
mmHg (8.0-9.3 kPa). Those COPD patients who retain 
carbon dioxide at rest are generally more hypoxaemic, 
with Pa,02 often being in the 40-60 mmHg (5.3-8.0 
kPa) range. A similar broad range of Pa,02 is seen in 
ILD and PVD. Pa,C02 is usually normal or slightly re­
duced in those COPD patients with Pa,02 in the 60-70 
mmHg (8.0-9.3 kPa) range. Carbon dioxide retainers, 
of course, have an elevated Pa,C02s usually in the range 
45-55 mmHg (6.0-73 kPa), but again extremes exist 
with values as high as 70-80 mmHg (9.3-10.6 kPa) 
occasionally seen, even in stable out-patients. In ILD, 
Pa,C02 is typically 30-35 mmHg (4.0-4.7 kPa), as dis­
cussed previously. This is also true in PVD. From these 
general pairings of partial pressure of oxygen (P02) and 
partial pressure of carbon dioxide (Pco2), the alveolar 
gas equation can be used to deduce the alveolar-arter­
ial oxygen difference (DA-a,02):
DA-a,02 = (Pi,02 - Pa,C02/RER + 
(Pa,C02*Pl,02*(1 -RER)/RER)) - Pa,02 (2)
where RER is the respiratory exchange ratio (RER= 
V'CO2/V02) Pl£)2 is the inspiratory oxygen pressure and 
Pl,02 is the inspiratory oxygen fraction. This equation 
is derived from mass balance considerations of oxygen 
and carbon dioxide exchange between the air and the 
alveolar gas and assumes constancy of lung nitrogen 
stores. Thus, even if V'02i V'C02 and V'E are changing, 
the DA-a,02 can be validly computed if there is nitro­
gen balance between inspiration and expiration. It is 
important to recognize that the absolute blood-gas val­
ues and the DA-a,02 yield different, but complementary 
information. The DA-a,02 reflects primarily pulmonary 
defects in gas exchange caused by V'A IQ' mismatch­
ing, diffusion limitation and shunt either alone or in 
combination. It can, however, be modified by changes 
in cardiac output or ventilation even in the absence of 
change in V'A IQ' distribution. The typical response to 
exercise in COPD is a small rise in Pa,C02 and a sim­
ilar, or even greater, fall in Pa,02. However, Pa,02 fre­
quently does not fall, and may even increase in some 
subjects. Studies using the multiple inert gas elimina­
tion technique show that V'AlQ' mismatch is usually 
unaltered from that at rest in COPD, that shunts do not 
develop, and that diffusion limitation also does not oc­
cur [16, 35]. This is particularly so when COPD is 
severe. In milder disease, there is evidence that small 
improvements in V'A IQ' relationships may occur on
exercise [18]. The blood-gas changes on exercise are 
mostly the consequence of how alveolar ventilation 
increases compared to V'02 and V'C02, with secondary 
effects from the fall in mixed venous Po2. However, it 
is not infrequently observed that when the patient with 
COPD is encouraged to maximal effort, sudden hypox­
aemia and hypercapnia can develop. In ILD the blood- 
gas changes with exercise are usually more typical and 
substantial even at moderate effort. While Pa,C02 is gen­
erally unaffected, Pa,02 falls in almost all patients with 
diffusion limitation being contributory [23]. It is remar­
kable that diffusion limitation of oxygen exchange can 
occur even at a cardiac output of less than 10 L*min_I 
during exercise in ILD, However, as with COPD, the 
amount of V'AfQ' mismatching and shunt appear not to 
change with exercise [23]. In PVD, Pa,02 usually falls 
by several millimetres of mercury, Pa,C02 also falls by 
perhaps 3-5 mmHg (0.40-0.67 kPa), and the DA-a,02, 
thus, increases. As with ILD, this is found to be large­
ly due to the large fall in venous Po2 rather than a syste­
matic change in Va/Q ’ relationships [23], and diffusion 
limitation may also develop.
Cardiovascular response
It should be remembered that patients with lung dis­
ease are subject to the same general cardiovascular dis­
orders as anyone else. Those with COPD in particular 
share risk factors for ischaemic heart disease due to ciga­
rette smoking, age and inactivity, and in addition they 
are generally hypoxaemic. However, throughout the fol­
lowing discussion, ischaemic heart disease is assumed 
not to be present. Also, it is well known that eventual­
ly many patients with either COPD or ILD will devel­
op cor pulmonale with right heart failure from their lung 
disease. This will also happen in PVD. While the pul­
monary circulation shows evidence of abnormality well 
before frank right heart failure develops, the following 
discussion is limited to those patients who have not yet 
reached the stage of clinical right heart failure. Typically 
cardiac output increases per unit increase in metabolic 
rate even in patients with very severe lung disease [16, 
36], except in some with PVD. This is true even if car­
diac output is somewhat reduced at rest. However, at 
peak exercise in these forms of lung disease, cardiac 
output is about 50% (less in PVD) of what a normal 
older subject could achieve at peak exercise [18, 36]. 
There are two possible explanations. First, the control 
of cardiac output during exercise in lung disease may 
remain so tight that, despite the capacity for a higher 
cardiac output, it remains regulated to match the level 
of V'02 achieved. The second is that despite absence of 
overt heart failure, cardiac function is indeed compro­
mised and a higher cardiac output could not be achiev­
ed. Pulmonary hypertension is often evident even at 
rest, and usually worsens during exercise. The increase 
in pressure per unit increase in cardiac output is some­
times three times greater in the patient groups than in 
normal subjects. In normal subjects, although pulmonary 
artery pressure normally rises during exercise, pulmon­
ary vascular resistance normally falls due to a combina­
tion of vascular recruitment and distension in the lungs. 
In ILD, PVD and severe COPD on the other hand, vas­
cular resistance remains constant or may even rise [18,
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23, 24]. The reason is vascular destruction or obstruc­
tion, which is known to occur in these diseases, and hypo­
xic vasoconstriction. Eventually, as the diseases progress, 
the right heart will hypertrophy and ultimately fail, and 
clinically significant cor pulmonale will be present.
Despite the marked increase in vascular resistance, it 
is remarkable that even in advanced disease the heart 
can pump in an essentially normal manner as a func­
tion of filling pressure if heart failure is not present. 
Cardiac frequency (fc) at a given V'o2 is higher than 
normal in subjects with these lung diseases. This im­
plies that stroke volume must be lower* Whether this is 
simply an extension of the phenomenon in health, where­
by unfit subjects have a higher fc than fit persons at 
the submaximal Vr02, is unclear. The oxygen pulse (V'o2 
per heart beat) is an index that is in common current 
use (see [2] pages 65-66 and 119-120 for discussion) 
because: 1) of its noninvasive nature; and 2) it is quan­
titatively equivalent to the product of stroke volume and 
arterial minus mixed venous oxygen difference. This 
will be lower in lung disease if fc  is higher. However, 
despite the fc  being higher at the same V'o2 than in 
health, fc  at peak V]02 is almost always less than pre­
dicted. As the V'o2-cardiac output relationship is gene­
rally normal, the arteriovenous oxygen concentration 
difference will also be normal for a given V'02. However, 
both arterial and mixed venous Po2 levels are reduced 
due to the hypoxaemia of lung disease. Interestingly, 
mixed venous Po2 at peak exercise in health is about 
the same as in lung diseases, despite the much higher 
peak Vo2 in health.
Limits to exercise
At levels of effort below peak or maximal, patients 
with lung disease may have a total ventilation and car­
diac output increase, at a given V'02, at least as much 
as in health even if respiratory muscle and cardiac work 
and the patient's symptoms are greater. The physiolog­
ical basis for reduction in peak or maximal V'02 is of 
major interest. The reduction in peak Vo2 in COPD 
patients, for example, sometimes cannot be accounted 
for simply by "ventilatory limitation"; in fact, leg fatigue 
is a commonly reported end-exercise symptom in these 
patients [17], Although they may not have been able to 
achieve higher ventilation breathing room air because 
of their lung disease, there are two additional factors 
of considerable quantitative importance contributing to 
the low peak V'o2. Firstly, the cardiac output at peak 
exercise is about 50% of the value that a normal age- 
matched subject would achieve at maximal effort. Whe­
ther this represents cardiac dysfunction or, as stated, 
earlier manifestation of the tight regulation between 
V02 and cardiac output, is uncertain. However, oxygen 
transport would presumably have been greater had car­
diac output reached normal maximal values and (sub­
ject to not having reached mitochondrial oxidative 
limitation) the same would have been true of maximal 
V'02. A second factor that might decrease peak V'02 is 
a reduction in muscle oxygen conductance [37], result­
ing from inhomogeneity between local muscle oxygen 
and blood flow or to reduced diffusional conductance, 
possibly the result of myopathic capillary Tarification.
Had the muscle conductance been normal, peak Vo2 
could then have been greater even at the same cardiac 
output and It is also unclear whether simple lack 
of fitness or additional pathological factors are respon­
sible. Of course, if V'02 could be improved by such the­
rapeutic gains, V'C02 would rise accordingly and provide 
an added burden to ventilation that might still prevent 
the anticipated gain in V'O^ max. Recognizing the poten­
tial capacity for factors other than ventilation to limit 
exercise in lung disease is important in attempting to 
correct the primary lung problem, e,g. by transplanta­
tion. For example, the poor exercise responses after 
organ transplantation in cardiopulmonary diseases are 
likely to be due, at least in part, to unrecognized and 
untreated defects in skeletal muscle blood flow and oxy­
gen transport.
Indications
There is a range of indications for CPET, as outlined 
in table 1. It is useful, for example, in the diagnosis of 
a range of disease conditions, such as: 1) exercise-induced 
asthma; 2) cardiac ischaemia; 3) foramen ovale paten­
cy with development of right-to-left shunt during exer­
cise [2]; and 4) McArdle's syndrome [38]. In addition, 
CPET provides information on dysfunction, monitoring 
and prognostic value in a wide range of conditions (table
1; [5]).
However, an adequate identification of the clinical 
problem requiring study should be considered a neces­
sary prelude to CPET, as should an appropriate assess­
ment of the patient by: 1) medical history; 2) physical 
examination; 3) chest radiograph; 4) pulmonary func­
tion testing; and 5) electrocardiogram (ECG). The clin­
ical problem that prompts the CPET and the specific 
aims of the test {i.e. assessment of exercise tolerance, 
analysis of pulmonary gas exchange during exercise,
Table 1. -  indications for cardiopulmonary exercise 
testing with reference to lung diseases
Assessing exercise tolerance and potential limiting factors
Identification of abnormal limitation of exercise intolerance, 
and discrimination among causes of exercise tolerance 
Differentiation between dyspnoea of cardiac or pulmonary ori­
gin
Evaluation of unexplained dyspnoea when initial pulmonary 
lung function impairment does not provide conclusive results 
Assessing impairment in chronic lung diseases 
Interstitial lung diseases 
Chronic obstructive pulmonary disease 
Marked hypoxaemia during exercise 
Occult cardiac disease 
Abnormal breathing pattern during exercise 
Chronic pulmonary vascular occlusion (controversial)
Cystic fibrosis 
Preoperative assessment
Major abdominal surgery, especially in elderly patients 
Lung cancer resectional surgery 
Resectional surgery in pulmonary emphysema 
Diagnosis of exercise-induced asthma 
Rehabilitation programmes: patient assessment and exer­
cise prescription
Assessment of impairment-disability 
Lung, heart-lung transplantation
Modified from [5].
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Select appropriate reference values 
to establish patterns of abnormal response
Compare with characteristic patterns
of relevant diseases
Fig. 1. - Logical strategy to approach cardiopulmonary exercise 
testing (CPET) in a clinical setting. ECG: electrocardiogram.
etc) determine both the type of exercise protocol to be 
used and the variables to be considered in the interpre­
tation of the test (fig. 1). These are described in detail 
below (see sections on exercise protocols and interpre­
tation strategies).
Assessing exercise tolerance and potential limiting fac­
tors
Exercise performance and V'02 peak cannot be val­
idly predicted from resting cardiopulmonary testing. 
This is especially true in patients in whom exercise is 
limited by lung function [3-9]. This is not only because 
exertional dyspnoea is not well predicted from pul­
monary function, but also because many patients with 
lung disease stop exercising owing to fatigue, chest pain 
and leg discomfort rather than dyspnoea [3], For these 
reasons and because measures of health-related quality 
of life correlate better with exercise tolerance than with 
either spirometry or oxygenation [9], CPET is a useful 
tool in the integrated evaluation of common problems 
such as unexplained dyspnoea on exertion and limita­
tion of exercise tolerance [39, 40]. Appropriate use of 
CPET allows the investigator: 1) to quantify the degree 
of abnormal limitation and to discriminate among cau­
ses of exercise intolerance; 2) to differentiate between 
dyspnoea of cardiac or pulmonary origin when respi­
ratory and cardiac diseases coexist; and 3) to analyse 
unexplained dyspnoea when initial pulmonary function 
impairment does not provide conclusive results [5,40].
Assessment of impairment in chronic lung diseases
Comprehensive CPET can be extremely useful in dif­
ferent phases of the decision-making process in chro­
nic lung diseases.
Interstitial lung diseases, Assessment of pulmonary gas 
exchange during exercise [23, 41-43] in the clinical 
evaluation of ILD is fundamental to early diagnosis, 
staging of dysfunction and monitoring of therapy. More­
over, recent data in a rather small group of subjects [44] 
seem to suggest that CPET might also have a progno­
stic value in idiopathic ILD.
Chronic obstructive pulmonary disease. Use of CPET 
to assess the severity of dysfunction in COPD can be 
valuable in the detection of situations that may prompt 
therapeutic decisions to ameliorate the consequences of 
the disease such as: 1) marked hypoxaemia during exer­
cise (needs for supplemental oxygen can be assessed 
directly; 2) occult cardiac disease (initiate appropriate 
therapeutic regime); or 3) inefficient breathing patterns 
during exercise (initiate rehabilitation programme?). Use 
of CPET in prospective trials may also provide inform­
ation in the evaluation of new experimental therapeu­
tic approaches such as resectional surgery in pulmonary 
emphysema [45, 46],
Chronic pulmonary vascular occlusion. It has been 
shown that V'o2 peak is closely correlated to the amount 
of functional vascular bed in chronic pulmonary vas­
cular occlusion [22, 47]. However, exercise testing in 
such patients carries a significant mortality risk and 
should not be performed when there is a history of arr­
hythmias or syncope, or clinical signs of right heart fail­
ure. Furthermore, the power output attainable during 
exercise in patients with primary pulmonary hyperten­
sion correlates well with haemodynamic variables mea­
sured at rest [48-50]. Consequently, indications of CPET 
in such patients should be carefully established on an 
individual basis.
Cystic fibrosis. There is evidence to support the use of 
CPET as a tool in the prognosis and management of 
patients with cystic fibrosis [51].
Preoperative assessment
Major abdominal surgery in elderly patients. While mor­
tality remains high in elderly patients undergoing major 
abdominal surgery, chronological age is a poor guide 
to physiological status. It has been suggested that reduc­
tion of cardiopulmonary reserve during exercise can 
provide a reasonable prediction of mortality following 
major surgery [52, 53]. It has been suggested that there 
is a need for a system for grading operative risk that 
includes evidence of abnormal cardiopulmonary func­
tion based on CPET.
Preoperative assessment of lung cancer resectional 
surgery. Information on predicted postoperative lung 
function: 1) helps to modulate the amount of lung par­
enchyma to be resected; and 2) determines the type of
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preoperative strategy needed to prevent postsurgical 
complications. Resting pulmonary function tests are 
considered adequate to evaluate patients with low risk 
(forced expiratory volume in one second (FEVl) >2 L 
and transfer factor of the lung for carbon monoxide 
(TL.CO) within the reference limits) of postsurgical com­
plications [54-59]. However, CPET plays a pivotal role 
in the evaluation of patients with moderate to high risk
[57, 58, 60, 61].
Preoperative assessment of lung-reduction surgery, 
Lung-reduction surgery [45,46, 62] is the newest thera­
peutic option for patients with emphysema, but still re­
quires further evaluation. As indicated above, CPET plays 
a key role in this type of surgery, both in the selection 
of potential candidates and to establish the programme 
of physical rehabilitation before and after surgical in­
tervention.
Rehabilitation programmes : patient assessment and exer­
cise prescription
Exercise therapy should be part of rehabilitation pro­
grammes that aim to improve both quality of life and 
physiological status in patients with COPD and other 
forms of chronic lung disease [3, 63-72]. CPET should 
always play a central role in the assessment of candi­
dates before the rehabilitation programme and in the 
subsequent modulation of the exercise prescription, 
whereas simpler tests (i.e. 6 min walk) are useful for 
monitoring during the rehabilitation programme.
While it is accepted that physical training can pro­
duce physiological improvements in patients with mod­
erate to severe COPD - such as: 1) increase in exercise 
tolerance (V'02 peak) [71]; 2) decrease in ventilatory re­
quirements [73]; and 3) faster oxygen kinetics [74] - 
controversy still remains regarding the type of training 
programme that is most appropriate [63-65].
Assessment of imp air ment-dis ability
It is now well accepted that CPET provides different 
and relevant information in impairment-dis ability eval­
uation [5-7], compared to resting cardiopulmonary mea­
surements [75]. Consequently, CPET constitutes a key 
tool in this area. Clarification of this field should be 
greatly facilitated with the adoption of the conceptual 
framework proposed by the World Health Organization 
(WHO) [76]. According to the WHO, the illness-rela­
ted phenomena should be classified in three different 
categories: 1) impairment, used to describe loss of func­
tion; 2) disability, corresponds to the resulting reduc­
tion in exercise capacity; and 3) handicap, the total 
effect of the illness on the subject's social life.
Lung, he art‘lung transplantation
Lung and heart-lung transplantation are now accep­
ted as viable therapeutic options for patients with end-stage 
vascular and parenchymal lung diseases. CPET is a use­
ful tool in the preoperative phase of the evaluation of 
the patient's impairment. CPET may also contribute to
the evaluation of disease progression [77], the appro­
priate timing for surgical intervention [78, 79], and can 
be used to guide preoperative rehabilitation [48, 80- 
83]. As yet, however, there are no recommendations as 
to how indices of exercise performance should be used 
in the decision-making process of when a patient should 
be selected for a lung transplant. In contrast, such re­
commendations do exist, and have been successfully 
applied, in candidates for cardiac transplantation; sur­
vival has been shown to be well con-elated with V'02 
peak [78,79].
Several studies have shown that pulmonary and car­
diac function are typically satisfactory in patients with 
adequate allograft tolerance. The majority of these 
patients report considerable improvement in functional 
outcome and life satisfaction, often with resumption of 
a normal life style. The available post-transplant data 
demonstrate that virtually all recipients have persistent 
exercise impairment, regardless of the underlying dis­
ease or type of transplant procedure [83]. This is prima­
rily attributed to skeletal muscle dysfunction [83-85]. 
In the postoperative phase, CPET is useful in the assess­
ment of limitation of exercise tolerance, discriminating 
among its potential causal factors and as a guide to post­
operative rehabilitation.
Protocols
The goal of CPET protocols is to stress the organ 
systems involved in the exercise response in a controlled 
manner. For this reason the testing generally involves 
exercising large muscle groups, usually the lower extre­
mity muscles. A key requirement is that exercise stim­
ulus be quantifiable in terms of the external work and 
power performed. Simpler tests, such as step tests or 
timed distance walks (i.e., 6 or 12 min walk) can pro­
vide measures of exercise tolerance, but are not as use­
ful in diagnosis as incremental tests [1, 2, 87]. The 
purpose of this section is to describe the characteristics 
of recommended clinical exercise protocols, both in­
cremental and constant work rate tests.
Standard clinical exercise protocol: incremental test
The appropriateness of the integrated systemic res­
ponses to the tolerable range of work rates are best stud­
ied utilizing incremental exercise testing [88] (fig. 2). 
This provides a smooth gradational stress to the sub­
jects so that the entire range of exercise intensities can 
be spanned in a short period of time. Technological ad­
vances (see section on equipment) have made it possi­
ble for sufficient density of data to be acquired in a test 
lasting less than 20 min (fig. 3), including: 1) mea­
surements at rest; 2) 3 min of unloaded exercise; 3) in­
cremental exercise (approximately 10 min); and 4) 2 
min recovery, at least. The recommended increment­
al exercise testing protocol, usually cycle or treadmill 
ergometry, is described in detail in the section on proce­
dures . Electronically braked cycle ergometry with con­
stant pedalling frequency, of 60 revolutions per minute 
(rpm) for example, is recommended (as discussed in the 
section on equipment). Equivalent results are obtained 
when work rate is either increased continuously (ramp
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Fig 2. - Graphical representation of standard incremental exercise 
protocols. Equivalent results are obtained when work rate is either 
increased continuously (ramp test) or by a uniform amount each minute 
(1 min incremental test) until the patient is limited by symptoms 
(he/she can not cycle >40 rpm) or is not able to continue safely. The
increment rates of 10 W-min-1 (-- ) to 20 W-mhr1 (---) is set
according to the characteristics of the patient in order to obtain approx­
imately 10 min duration of the incremental part of the protocol.
I
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Fig. 3. - Recommended incremental exercise protocol using an elec­
tronically braked cycle ergometer.
test) or by a uniform amount each minute (1 min incre­
mental test) until the patient is limited by symptoms 
(he/she cannot cycle >40 rpm) or is not able to conti­
nue safely. The increment size should be set according 
to the characteristics of the patient in order to obtain 
approximately 10 min duration of the incremental part 
of the protocol. This may represent incrementation rates 
of 10-20 W-min-1 in a healthy sedentary subject or less 
in a patient [1, 2, 87]. Modifications in the design of 
the protocol and/or the measurements to be carried out 
during the test can be considered depending on: 1) the 
characteristics of the subject (physically fit or severely 
limited); and 2) the clinical problem prompting the in­
dication of CPET (e.g., exercise-induced asthma, as 
described in detail by Sterk et al, [89]).
If the ergometer is a motor-driven treadmill, then 
Balke's protocol [90, 91] is considered the most appro­
priate for its simplicity. The speed of the treadmill is 
kept constant (5-6 km*lrl) during the protocol while 
the slope is progressively increased (1-2%-min-1).
Standard nonin vasive CPET carried out breathing 
room air (Fl,O2=0.21) involves acquisition of expired 
oxygen and carbon dioxide concentrations (Fe ,02 and 
Fe ,C02, respectively), WR, respired airflow, jfc and sys­
temic arterial pressure as primary variables. ECG and 
pulse oximetry should be continuously monitored dur­
ing the test. It is useful to establish a sense of the pati­
ent's exercise-related perceptions during the exercise test 
and at the point when the subject discontinues exercise. 
This includes exertion, dyspnoea, chest pain and skele­
tal muscle effort. Quantifying these perceptions should 
be done using standardized rating procedures (Borg 
scale, visual analogue scale (VAS), etc.) [92].
Interpretation of CPET results in patients with lung 
disease, however, often requires evaluation of pulmon­
ary gas exchange [91]. In these cases, arterial cannula- 
tion (preferably radial or brachial) is needed to obtain 
partial pressures of respiratory gases in arterial blood 
(Pato2 and Pa,C02) and to determine DA-a,02 [91, 93]. 
This also provides information on acid-base status (pH, 
Pa,C02 and base excess) and allows continuous moni­
toring of systemic arterial blood pressure during the 
test. However, while "arterialized venous blood1 (e.g. 
from the dorsum of the heated hand) gives good val­
ues for PC02 and pH it is not appropriate for Po2. Fur­
thermore, estimation of arterial respiratory blood gases 
through expired oxygen and carbon dioxide profiles or 
"transcutaneous" electrodes and pulse oximetry should 
not be used as indices of Pa,02 and Pa,C02 during exer­
cise [94-96], It is important to recognize that arterial 
blood sampling immediately after exercise does not pro­
vide an adequate assessment of blood gas values at peak 
exercise. However, while pulse oximetry does not indi­
cate arterial Pa,02, it does provide valuable information 
on oxyhaemoglobin saturation during exercise.
Other tests
Constant work rate exercise testing. Constant work 
rate exercise can result in steady-state responses when 
work rate is of moderate intensity (fig. 4). In contrast,
Fig. 4. - Time course of oxygen uptake during constant work rate 
exercise in one healthy subject (-- ) and one COPD patient (— —).
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a constant work rate of high intensity for the individ­
ual typically results in continually changing values in 
most variables of interest. Consequently, attainment of, 
or failure to attain, a steady-state V'02 during a con- 
stant-load test can be used to determine if a particular 
task is sustainable by the individual.
However, even for moderate exercise, steady-state 
cardiorespiratory responses do not occur instantaneou­
sly when exercise begins; rather, they change over a 
period of several minutes, but at rates which are dif­
ferent for each variable (Vo2, V'CO2,jfc and VE). It has 
been demonstrated that both cardiopulmonary disease 
[13] and level of fitness [97] modify the time course of 
the nonsteady-state responses to exercise. Hence, the per­
iod of dynamic adjustment to a constant work rate test 
provides information regarding the dynamic behaviour 
of lung function, haemodynamics and tissue oxygen uti­
lization. However, there is, to date, virtually no infor­
mation on the confidence limits, reproducibility and 
predictive value of the derived parameters in patient 
populations. Consequently, the utility of quantifying dy­
namic responses to constant work rate exercise in clin­
ical exercise testing remains to be established.
Some factors, however, such as the work efficiency 
or the substrate mixture undergoing oxygenation res­
piratory quotient (RQ), require steady-state determina­
tion. It is necessary, in this case, to ensure that variables 
are measured only after the dynamic periods of adjust­
ments are completed.
The fc during constant work rate testing is commonly 
used as a guideline in exercise prescription (rehabilita­
tion programmes) based on the potential for self-moni­
toring and self-adjusting the exercise dose during training. 
Identification of a training effect following an exercise 
programme may also be based on the finding of a reduc­
tion in fc  for a given constant work rate.
Determining the need for oxygen supplementation dur­
ing exercise or titrating oxygen prescription is most rea­
sonably performed during submaximal constant work 
rate exercise, simulating levels of activity needed to 
perform daily activities [91]. Furthermore, because pat­
ients with COPD may be limited during exercise by 
impaired lung mechanics [2, 19, 26, 27], assessment of 
steady-state ventilation, and its pattern, might be of 
interest in evaluating the capacity for sustaining a given 
task.
It should be recognized that exercise recovery also 
follows a dynamic time course. Re-establishment of 
resting steady-state conditions following moderate exer­
cise requires a similar time as for reaching the exercise 
steady-state, whereas recovery is delayed for consider­
ably longer periods following high-intensity exercise. 
Even in young healthy subjects, resting levels of arte­
rial blood lactate concentration, for example, are not 
achieved until approximately 1 h after maximum exer­
cise.
Assessment of exercise-induced broncho constriction. 
Patients with reactive airways disease may experience 
bronchoconstriction following (or during) exercise. 
Exercise-induced bronchoconstriction (EIB) is observed 
in 70-80% of the population with clinically recogniz­
ed asthma [89, 98, 99]. However, up to 40% of chil­
dren with documented EIB have no symptoms of asthma
[100]. An exercise challenge is, therefore, often worth­
while for patients complaining predominantly of symp­
toms associated with exercise.
Respiratory water loss was identified as the stimulus 
by which exercise induces bronchoconstriction in the 
late 1970s and it was proposed that evaporative water 
loss induced cooling of the conducting airways causing 
them to narrow [101]. This later led to the proposal that 
EIB occurred as a result of vascular engorgement dur­
ing rapid rewarming of the airways at the end of exer­
cise [102]. Other studies, however, have demonstrated 
that the dehydrating effects of water loss are more impor­
tant than the cooling effects. This led to the suggestion 
that an increase in airway osmolarity and release of 
mediators was the mechanism whereby the airways nar­
rowed in response to exercise [103, 104]. At present, 
there is no direct experimental evidence to support either 
of these hypotheses.
However, these proposals led to the conclusion that 
tests for EIB should aim to achieve a high level of ven­
tilation (V'E 15-22 times the predicted FEVi) while 
breathing air containing less than 10 mg-L-1 of water 
(20~25°C and <50% relative humidity). Breathing com­
pressed air via a valve will ensure low humidity of the 
inspired air. Recording ventilatory and gas exchange 
responses during the exercise period allows the level of 
Ve and metabolic stress to be documented.
The required V'E can be achieved either by running 
on a treadmill or by cycling [105]. Exercise performed 
with a cycle ergometer, however, is generally preferred 
because: 1) the breathing valve is more easily suppor­
ted; 2) measurement of ventilation is easier; and 3) the 
work rate is largely independent of body weight. The 
target work rate can be estimated by equations relating 
Ve to Vo2 and Vo2 to work rate. For treadmill exer­
cise, body weight becomes a more important factor for 
consideration [106, 107] (table 2). The protocol rec­
ommended consists of a rapid increase in the work rate 
to the target value within 3-4 min and sustaining the 
target V’E for at least 4 min. For the first, second and 
third minutes of cycling the work rate may be conve­
niently set to 60, 75 and 90% of the target value. At 
the beginning of the fourth minute the target work rate 
is set and Ve carefully monitored [89, 98],
In the patient with EIB, values for FEVi generally 
fall to a minimum within the first 10 min after cessa­
tion of exercise, with substantial recovery by 30 min 
postexercise, A useful protocol to assess the response 
to exercise is to perform forced spirometry before (fol­
lowing recommended standardization) and then FEVi 
manoeuvres at 1,3, 5, 7, 10, 15 and 20 min after exer­
cise. The response is assessed as the percentage fall in 
FEVi postexercise. The lowest FEVi recorded after 
exercise is subtracted from the pre-exercise value and 
the difference is expressed as a percentage of the pre-exer- 
cise FEVi. A greater than 10% fall in FEVi after exer­
cise is regarded as abnormal and >15% as diagnostic 
of EIB. For a drug to be."protective", the fall in FEVi 
after exercise should be less than 50% of that docu­
mented on placebo. The coefficient of variation of the 
exercise response (percentage fall in FEVi after exer­
cise) is 20% or less when two tests are performed under 
the same conditions within one month.
If the test is negative, it is important to check that:
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Table 2. - Conditions for evaluating the presence and severity of exercise-induced bronchoconstriction (EIB)
Safety
Risk factors or contra-indications for exercise should be assessed when considering patients with EIB.
Oxygen saturation at rest should be >94% and pulse oximetry should be continuously monitored during the test, in addition to
adherence to general guidelines for safety
Measurement
FEVi measurement is mandatory, pre-exercise and 1,3, 5, 7, 10, 15 and 20 min postexercise. In elite athletes, FEF25-75 should 
also be measured to assess EIB 
FEVi at rest
>75% predicted or 80% of patient's usual value (if known) and reproducible i.e. <10% variation 
Medications to be withheld
6 h for short acting bronchodilators, sodium cromoglycate and nedocromil sodium 
24 h for long acting bronchodilators, theophylline and antihistamines 
No steroids or caffeine on the study day 
Factors to be controlled for 
EIB >3 h
Infection >6 weeks
Exposure to pollen (test best performed out of season for pollen sensitive subjects)
Type of exercise
Cycling or running. Cycling is recommended as safest and easiest 
Intensity of exercise
V'02 sufficient to raise exercise V'E (L-min-1) to 18.5±3.5 times predicted FEVi for at least 4 min 
V'E (L-mhr1) = 28 V’02 (L-miir1) + 0.27 
V'o2 (mL-min-i) = ¡0 W + 500
For treadmill, V'o2 target will need to be greater than 35 mL-kg^-min-1 to achieve required V'E (see references [98, 106, 107]). 
Duration of exercise
6-8 min to allow target V'E to be achieved and sustained for at least 4 min 
Inspired air
Compressed dry air is recommended
Room air containing <10 mg J^O-I/1, temperature <25°C, <50% relative humidity is adequate,
Cold air only needed if it represents environmental conditions 
Index of severity
If patient not taking inhaled or oral steroids: AFEVl 10-25%: mild
AFEVl 25-50%: moderate 
AFEVl >50%: severe
Recovery
Spontaneous or with administration of a (32-agonist.
Supplemental 0 2 should be provided if needed at any time during the test
FEVi: forced expiratory volume in one second; FEF25-75: forced midexpiratory flow; V'o2: oxygen consumption; V’E: minute 
ventilation; A: change in.
1) the pre-exercise lung function was not unusually low;
2) the target V'E was achieved and sustained for at least 
4 min; and 3) the water content of the inspired air was 
<10 mg H20*L'1. While cooling the inspired air can 
increase the severity of the airway response in some 
subjects, this same effect appears to be achieved by pro­
longing the duration or increasing the intensity of exer­
cise under temperate inspired air conditions [108]. It 
should be noted, however, that exercise itself is not 
required to achieve the target ventilation and voluntary 
eucapnic hyperventilation of air containing approxi­
mately 5% carbon dioxide can be performed [109,110].
The protocol recommended is appropriate for both 
general laboratory assessment of EIB and evaluation 
of the protective effect of pharmacological agents [111, 
112]. To maximize the likelihood of a positive response, 
bronchodilator agents, sodium cromoglycate and nedo­
cromil sodium should be withheld prior to exercise for 
a period commensurate with their duration of action 
[112, 113]. Furthermore, the subjects should avoid vig­
orous exercise for at least 2 h prior to testing. During 
the test, in addition to routine safety precautions requir­
ed for all exercise testing, it is important to have rapid­
ly acting inhaled bronchodilators (e.g. salbutamol) 
available to reverse a severe episode of bronchospasm.
Equipment and quality-control programme
Choice of ergometers
Two modes of exercise are commonly employed in 
cardiopulmonary exercise tests: treadmill and cycle ergo­
meters. The motor driven treadmill is used to impose a 
progressively increasing exercise stress through a com­
bination of speed and grade (slope) increases. Several 
incremental protocols are popular [90,114-118]. During 
treadmill exercise testing a somewhat larger muscle mass 
can be brought to bear than in cycle ergometry, leading 
to a greater stress of the organ systems mediating the 
exercise response. On average, maximal oxygen uptake 
is reported to be 5-10% higher on a treadmill than on 
a cycle ergometer [119-122], This may be important to 
detect abnormalities (i.e. cardiac ischaemia) that occur 
only with the highest metabolic demand. The main dis­
advantage of using a treadmill is the difficulty of quant­
ifying the work rate accurately. The relationship between 
speed and grade of the treadmill and the metabolic cost 
of performing work is difficult to predict: the "walking 
skill" and pacing strategy are important determinants. 
Holding on to the treadmill handrails can substantially
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modify the metabolic cost of treadmill walking, but by 
an unpredictable amount. These uncertainties make the 
profile of Vo2 increase difficult to interpret. The rela­
tionship of other variables to Vo2, however, remains ap­
propriate.
For laboratory exercise testing, there are several ad­
vantages in using a cycle ergometer. It is generally 
cheaper and requires less space. It is less prone to intro­
duce movement or noise artefacts into measurements 
(i.e. blood pressure auscultation is generally easier). The 
most important advantage, however, is that the rate at 
which external work is performed is much more easi­
ly quantified. Although the metabolic cost of moving 
the legs at ostensibly zero load is a confounding factor 
[2, 123-125], this represents a constant offset as long 
as the pedalling cadence is kept constant. The pre­
dictability of the relationship between the imposed cycle 
ergometer work rate and the metabolic energy expen­
diture is important for disease evaluation.
The electronically-braked cycle ergometer [126] is 
generally used in CPET. Friction-braked cycle ergo- 
meters [127] generally provide a work rate that varies 
with the cycling frequency. In contrast, the electroni­
cally braked cycle ergometer allows direct quantifica­
tion of the work rate performed, which is usually 
independent of cycling frequency. It can also be readily 
computer controlled; this allows the work rate to be in­
cremented continuously (ramp exercise) [88,128-132]. 
Recently, cycle ergometers have become available that 
allow "true unloaded'1 pedalling (i.e. internal resistance 
of the ergometer is overcome by means of a motor 
"assist"). A lower starting work rate can therefore be 
selected; this is important for the most debilitated patients.
Gas exchange measurements
A central focus of comprehensive CPET is the inter­
pretation of gas exchange responses. Consequently the 
methods used to measure V'o2 and carbon dioxide out­
put V'C02 are of important. However, these measurements 
are not trivially easy to make, and a clear understand­
ing of the methods involved and the required quality 
control procedures are necessary prerequisites.
The technologically simplest technique of measuring 
gas exchange involves directing the expired air into a 
collection bag by use of a suitable breathing valve. A 
timed collection is made; the mixed concentrations of 
carbon dioxide and oxygen in the bag and the volume 
of the bag are subsequently measured. This allows cal­
culation of Vo2 and Vco2 [91, 133, 134]. By conven­
tion, V102 and V'C02 are expressed under standard 
temperature and pressure, dry (STPD) conditions while 
ventilation is expressed at body temperature and pres­
sure, saturated with water vapour (BTPS) (for complete 
definitions of STPD and BTPS, see Appendix). Use of 
highly accurate gas analysers is, naturally, essential. 
Though careful attention to technique is crucial, this 
method is capable of very precise measurements even 
at high metabolic rates. However, it is less suitable for 
rapid incremental exercise protocols as it is cumber­
some and the resulting data density is relatively low. 
Bag collection systems are now mainly used as a val­
idation technique for more complex gas exchange sys­
tems.
Systems featuring mixing chambers allow continu­
ous measurement of Vo2 and V'C02 [2, 135, 136]. The 
subject respires through a breathing valve and expired 
air is directed through a baffled chamber. The concen­
trations of carbon dioxide and oxygen are measured 
continuously at the distal end of the mixing chamber. 
Expired volume is measured, usually breath-by-breath. 
Vo2 and Vco2 can then be calculated from the gas con­
centration signals. In the steady-state of exercise, mix­
ing chamber systems are capable of accurate metabolic 
measurements. However, since the washout of the mix­
ing chamber requires a finite time (which depends on 
the airflow), the volume and gas concentration signals 
will be misaligned in the unsteady-state, leading to inac­
curate calculations unless appropriate corrections are 
made. For incremental protocols commonly used in clin­
ical CPET, ventilation and mixed expired gas concen­
trations do not change rapidly and the accuracy of a 
well designed mixing chamber system may be quite 
acceptable (though care must be taken to recognize that 
slurring of the response profile is a necessary conse­
quence not only when variables change rapidly but also 
when they change direction (i.e., expired partial pres­
sure of oxygen (Pe,02) at the lactate threshold).
With the ready availability of on-line digital com­
puter analysis of physiological transducer signals, it has 
become practical to compute Vo2 and Vco2 breath-by- 
breath [137-141]. Utilizing algorithms first reported in 
1973 [137], a signal proportional to expired airflow and 
signals proportional to fractional concentrations of car­
bon dioxide and oxygen measured near the mouth are 
sampled at high frequency (typically 50-100 Hz). As 
shown schematically in figure 5, the breath is broken 
down into a number of parts and the V'C02 and V'o2 
computed for each interval. The measurements for each 
interval are summed over the expiration to compute the 
total volume of carbon dioxide exhaled and oxygen 
taken up in the breath.
V'C02 = 2 FE£o2-VE-At 
V'02 = 2 (Fl,02 - FE,02)*VE-At
where VE is the instantaneous expired airflow, At is the 
sampling interval and Fl>02, Fe ,02 and Fe,C02 are the 
fractional concentrations of inspired oxygen, expired
Fig 5. - Diagram illustrating calculation of breath-by-breath carbon 
dioxide output (VC02), which is derived from VC02 = Z^E,C0 2- 
V'E-At V'Exp: expired airflow; FE,C02; expired C02 fraction; At; sam­
pling interval.
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oxygen and expired carbon dioxide, respectively. These 
calculations must accommodate water vapour, baro- 
metric pressure and ambient temperature variations in 
order to obtain STPD values in addition to the "nitro­
gen correction factor" when only expired volumes are 
measured (see Appendix). As importantly, compensa­
tion is necessary for the delay between the time at which 
gas is sampled at the mouth and the time at which the 
gas concentration is measured within the gas analysers 
(usually in the order of 0.25 s). Breath-by-breath ana­
lysis, therefore, requires precise knowledge of (and 
computerized compensation for) the transport delays of 
both gas analysers [140, 142-144]. Thus, the increased 
temporal resolution of breath-by-breath analysis comes 
at a cost of more exacting quality control requirements.
Measurement of oxygen uptake when Fl,o2 is high 
presents particular problems. First, the source of inspir­
ed gas must have a constant oxygen fraction (i.e., from 
large gas bags). Further, when F l02 approaches 1, nitro­
gen balance corrections become more and more subject 
to error [142]. Depending on the methodology employ­
ed and the accuracy required, Fi,o2 of 0.8 or more should 
be regarded as beyond the practical upper limits of accu­
rate measurement of Vo2.
concentration functions) is beyond the scope of the pre­
sent document.
One can forego the necessity for serial blood samp­
ling and even, in many cases, enhance the discrimin- 
ability of LT by utilizing a particular cluster of ventilatory 
and pulmonary gas exchange responses, which provide 
noninvasive estimation of LT (V-slope method or time 
course of ventilatory equivalents for oxygen and car­
bon dioxide; see Appendix). However, the indiscri­
minate use of noninvasive estimators of LT should be 
discouraged. Without the supporting evidence that the 
more rapid rate of change of Vco2 or V'E is a conse­
quence of the developing metabolic acidemia, the change 
could also reflect any of a range of hyperventilatory 
causes of particular concern in patients with lung dis­
ease.
Furthermore, the validly of the noninvasive estima­
tion of LT under "complicating" conditions such as 
chronic hyperventilation, progressive exercise-induced 
hypoxaemia, and impaired peripheral chemosensitivity 
with an associated high airway resistance remains to 
be established.
Exercise testing measurement systems
The lactate threshold
Although there is no generally agreed upon proce­
dure for normalizing work intensity, most would con­
cede that the range of work rates within which there is 
not a sustained metabolic (chiefly lactic) acidemia (i.e., 
moderate exercise) may be sustained for long periods, 
but heavier exercise may not [2]. The threshold V'o2 
for arterial lactate concentration increase (the lactate 
threshold (LT)) may, therefore, be considered to parti­
tion exercise into moderate and heavy intensities, with 
important implications for the ability to sustain a par­
ticular work rate. However, it should be emphasized 
that physiological mechanisms underlying the increases 
in muscle and blood lactate concentration that occur 
above LT remain a highly contentious issue; some in­
vestigators even question whether the arterial lactate 
concentration profile actually provides evidence of thre­
shold behaviour [97, 145]. The lactate threshold may, 
therefore, be considered to: 1) partition moderate from 
heavy-intensity exercise; 2) trigger a series of physio­
logical responses that stress ventilation, pulmonary gas 
exchange, and acid-base regulation; and 3) have im­
portant implications for the ability to sustain muscular 
exercise, both in normal individuals and in patients with 
impaired systemic function.
Determination of LT. The lactate threshold is highly 
task-specific, It occurs at an appreciably lower V'02 for 
arm exercise than for leg exercise, and is typically lower 
for cycle ergometry than treadmill exercise, reflecting 
the magnitude of muscle mass over which the work is 
distributed, A wide range of techniques have been ad­
vocated for estimation of LT, including both direct mea­
surements and indirect estimation [91]. The description 
of the direct measurements of LT [146, 147] (arterial 
lactate concentration-pyruvate concentration ratio; log­
arithmic arterial lactate concentration and bicarbonate
High intensity data analysis and display of a range 
of relevant variables (e.g. [2]) is most likely to provide 
patterns of response that optimize discrimination (espe­
cially of subtle differences). Tests using less complex, 
and certainly less expansive equipment and procedures 
can also provide useful information, however, especially 
if the issue in question is well focused (see [116] for 
discussion). Figure 6 presents a schematic representa­
tion of the analytical devices that constitute a recom­
mended measurement system for CPET. The following 
components are usually present: 1) digital computer; 2) 
flow or volume measurement system; 3) gas analysers;
4) electrocardiograph (ECG); and 5) pulse oximetry. 
Measurement of systemic arterial blood pressure and 
analysis of respiratory blood gases [93,94] and acid-base 
status [2, 148] should also be considered part of the 
basic CPET equipment.
Digital computer. The analogue-to-digital converter 
needs to sample a number of signals at 50-100 Hz and 
the computer should be capable of computations of vari­
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Fig. 6. - Schematic representation of the equipment used for car­
diopulmonary exercise testing (CPET). A/D: analogue/digital.
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breath detection, often signalled by the detection of the 
onset of expiratory airflow. The breath-by-breath val­
ues of a number of variables should be available for 
on-line graphical or tabular display and should be stored 
for later analysis.
Flow or volume measurement of respired air. A num­
ber of transducers have been used for measurement of 
respired flow or volume during exercise. In part, the 
expansion of the choice of transducers has resulted 
from the use of computerized data analysis. A nonlin­
ear relationship between the actual flow or volume and 
transducer output can be accommodated by digital com­
puter processing, as long as the nonlinearity has been 
well characterized and is static (i.e., the relationship 
does not vary with time). Furthermore, the choice of a 
flow versus a volume transducer is no longer crucial 
since numerical integration or differentiation can be 
employed to calculate one quantity from the knowledge 
of the other. A key consideration is whether the trans­
ducer can be positioned near the mouth. Such trans­
ducers are capable of sensing bi-directional flow or 
volume. They also eliminate the need for a nonrebrea­
thing valve which means that the apparatus dead space 
can be lower. Both the ERS and the American Thora­
cic Society (ATS) have established standards for flow 
and volume measurement in the context of spirometry 
[149, 150] (table 3). The transducers used in CPET 
should also meet these standards. Transducers common­
ly employed for measuring flow or volume in CPET 
are listed below.
Pneumotachograph. This flow transducer measures the 
pressure drop across a low resistance screen [2, 119,
151, 152]. Since laminar flow and constant tempera­
ture are required and sputum impaction on the transdu­
cer screen can degrade performance, pneumotachographs 
have generally been positioned well downstream from 
the mouth. The latter two concerns, however, can be 
avoided by measuring inspired rather than expired air­
flow.
Pitot tube flowmeter. This device measures the differ­
ence between pressure at orifices facing the flow stream 
and orifices perpendicular to the flow stream. Turbu­
lent (rather than laminar) airflow is involved and the 
pressure difference is proportional to the square of the 
flow rate [2, 153].
Mass flow meter. This device is related to the older hot 
wire anemometer in which a wire is placed in the air- 
stream. The current required to heat the wire to a cer­
tain temperature increases as airflow increases [154, 
155]. In one configuration presently used, two wires 
heated to different temperatures are utilized; flow detec-
Table 3. -  Minimum requirements of the equipment
tion depends on the fact that the hotter wire loses heat 
more rapidly than the cooler wire. Compensation is made 
electronically for changes in gas temperature. The sig­
nal generated is (nonlinearly) proportional to the num­
ber of molecules passing the sensor rather than the 
volume of gas the molecules occupy.
Turbine volume transducer. A lightweight impeller is 
placed in the flow stream and the number of interrup­
tions of a light beam by the impeller are counted by a 
computerized system [156]. Although small, the mass 
of the impeller causes a small "start up" and "overrun" 
at the start and end of the breath, respectively; The dy­
namic non linearities can lead to errors in the timing of 
the breath [157].
Gas analysers. Different strategies have been employ­
ed to measure the gas concentrations necessary for 
breath-by-breath analysis. One is to use an analyser cap­
able of measuring all the relevant gases (carbon dio­
xide, oxygen and, for some purposes, nitrogen). Mass 
spectrometry has most often been used for this purpose. 
The other approach utilizes separate analysers for each 
gas species. Key requirements are stability and rapidity 
of response, The dynamics of analyser response has two 
separate components: transport delay (the time required 
for the gas to traverse the distance from the sampling 
site to the analyser) and analyser response (the kine­
tics of response to a change in gas composition intro­
duced into the analyser). Transport delay (generally in 
the order of 0.2-0.5 s, depending on the length of the 
gas sampling tube and the gas sampling rate) can be 
readily compensated for. The analyser response, often 
taking the form of an exponential or sigmoid response 
to a stepwise change in gas composition [138,139] must 
be kept as short as possible and included in the total 
1ldelay". An additional concern is the sensitivity of the 
analyser to the partial pressure of water vapour in the 
sampled gas. Since water vapour concentration in the 
sampled gas can be difficult to predict (principally be­
cause the gas temperature at the sampling point is dif­
ficult to predict), this can introduce substantial errors 
in metabolic rate calculations [134].
The mass spectrometer ionizes gas molecules in a 
high vacuum environment and then separates them (by 
one of several schemes) on the basis of mass to charge 
ratio. This enables the time courses of a number of gas 
species to be measured. These analysers are linear, often 
highly stable and have rapid response characteristics 
(analyser time constants of roughly 25-50 ms). They 
are usually configured to "ignore" water vapour, yield­
ing dry gas fractions. However, the high cost of mass 
spectrometers has inhibited their use in most commer­
cial CPET systems.
Discrete carbon dioxide and oxygen analysers have
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been designed specifically for the demands of cardio­
pulmonary exercise testing. Carbon dioxide analysers, 
based on absorption of infra-red light by carbon diox­
ide [158], are common. The oxygen analysers that are 
employed are different, based on two principles. In para­
magnetic analysers, the effect of oxygen molecules on 
a magnetic field is utilized. In the electrochemical ("fuel 
cell") analyser, high temperature reactions between oxy­
gen and substrate are measured. However, these dis­
crete oxygen and carbon dioxide analysers have potential 
disadvantages. While the analyser output is usually not 
a linear function of gas concentration, computerized 
correction for these nonlinearities can be made. Also, 
analyser measurements are influenced by water vapour 
concentration in the sampled gas. This problem has been 
circumvented by using sampling tubing composed of 
the polymer Nafion. This polymer contains sulphydryl 
residues that absorb water, allowing water molecules to 
be transported down its concentration gradient to the 
exterior of the tubing. The gas that reaches the analyser 
contains little water vapour.
ECG. Serial 12-lead ECG is optimal in subjects under­
going CPET for detection of disease. It is important to 
detect ST-segment and T-wave changes consistent with 
ischaemia and to define arrhythmias that occur with 
exercise [127, 159]. Three-lead ECG recordings for de­
tection of cardiac frequency are suitable in young sub­
jects in whom CPET is being used principally to define 
exercise tolerance. A key requirement is that electrodes 
should be properly placed using sweat resistant adhe­
sive patches and the detection electronics be specially 
designed for movement artefact rejection. Computerized 
systems enabling continuous display contribute to test 
safety; averaging of ECG complexes can improve de­
tection of ischaemic changes. Extensive description of 
electrode placement in 12~lead ECG and requirements 
of ECG recording in CPET can be found elsewhere 
[160].
Pulse oximetry. The current generation of pulse oxi­
meters detect the variation in transmission of light of 
two different wavelengths that occur with arterial pul­
ses in an extremity (usually the finger or ear lobe). Be­
cause oxygenated and reduced haemoglobin transmit 
certain wavelengths of light differently, this informa­
tion can be used to estimate arterial oxygen saturation 
(iSa,02) [94]. While useful and convenient for continu­
ous monitoring [161, 162], several concerns need to be 
kept in mind in the context of exercise testing. Pulse 
oximeters have limited accuracy (95% confidence lim­
its of ±4-5% as compared to directly measured Sa,o2) 
[163]. Some authors have reported that pulse oximeters 
tend to overestimate true 5a,o2 values [164-166], a parti­
cular problem when test results are being used to pres­
cribe oxygen therapy. On the other hand, poor perfusion 
of the extremity (yielding decreased pulsatility), which 
may occur in cardiovascular disease, may yield falsely 
low readings [167]. Movement and stray light can yield 
artefacts and dark skin colour can interfere with signal 
detection [168, 169]. Furthermore, the inherent limita­
tions of pulse oximetry must be appreciated [91]. These 
devices cannot detect the effects of increased carboxy- 
haemoglobin (or methaemoglobin); its calculations appro­
ximate the oxygenated fraction of available haemoglo­
bin. An additional disadvantage of pulse oximetry is 
that iSa,02 rather than Po2 is measured. Pa,02 (and the de­
rived variable DA-a,02) are more relevant in assessing 
the effects of lung disease on pulmonary gas exchange.
Systemic arterial blood pressure. Auscultation of blood 
pressure becomes more difficult during exercise because 
of the increase in ambient noise. Yet detection of exer­
cise induced hypertension (or, less commonly, hypoten­
sion) is an important goal in many circumstances [127]. 
Automated blood pressure measurement systems have 
been developed specifically for use during exercise. 
Many operate with the oscillometric method, in which, 
as the cuff is automatically deflated in stages, pressure 
oscillations induced within the cuff by pulsations in the 
arm are detected [170]. Despite algorithms designed to 
decrease the effects of artefacts, blood pressure mea­
surements may be inaccurate when, for example, the arm 
moves during the measurement cycle. Periodic checks 
against manual determinations are important.
For studies in which a radial or brachial artery cathe­
ter is inserted to facilitate blood sampling, it may be 
useful to measure blood pressure directly. It should be 
appreciated that there are (modest) systematic differ­
ences between auscultated and intra-arterial blood pres­
sure measurements [121, 171]. Miniature transducers 
that can be attached to the arm while the subjects exer­
cises are available. Meticulous attention to technique 
(/.£., exclusion of air bubbles) is necessary, as elsewhere 
with CPET, to ensure a good frequency response. Ste­
rility concerns have led some laboratories to use sin- 
gle-use disposable blood pressure transducers, Proficiency 
guidelines for the analysis of arterial blood gases should 
be followed.
Quality control programme
For CPET systems purchased as a unit, the manufac­
turer should be required to bear responsibility for demons­
trating that the system is capable of accurate measurement. 
This might include description of bag collection com­
parisons over a range of metabolic rates and with a vari­
ety of breathing patterns. Algorithms used for breath 
detection and for calculation of variables should be pro­
vided to the user. However, it must be stressed that the 
user bears the responsibility for ensuring that measure­
ments are accurate and reproducible on a day-to-day 
basis. CPET, especially when it features breath-by-breath 
gas exchange analysis, requires meticulous attention to 
calibration procedures to ensure accurate and repro­
ducible measurements (table 3). A good practice is to 
maintain a calibration log book so that long term trends 
can be monitored and sudden changes recognized and 
addressed.
Daily calibration begins with the determination of 
ambient barometric pressure, temperature and relative 
humidity. Several other calibration manoeuvres are per­
formed daily (or more often if many tests are done) to 
check the operation of key transducers. Most commer­
cial exercise systems facilitate these calibrations.
Verification of calibration of the airflow or volume 
transducer can be performed with a precision large vol­
ume syringe (e.g. 3 L). A wide range of flow rates
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should be performed to simulate the range of flows that 
occur between rest and heavy exercise; syringe strokes 
varying from 1-10 s in duration cover most of this range. 
Agreement in calculated volumes to within ±3% signi­
fies adequate performance [149, 150].
Although the output of most carbon dioxide and oxy­
gen gas analysers is a nonlinear function of gas con­
centration, electronic algorithms aim to create linear 
outputs over the desired operating range. For carbon 
dioxide, this is usually 0-8%; for oxygen it is 13-21% 
(unless testing with hyperoxic gas mixtures is inten­
ded). At least daily, a minimum of two point calibra­
tions of each analyser (with at least two precision gas 
mixtures) should be performed. On occasion, certified 
tanks with other relevant compositions should be used 
to verify linearity. This is conveniently done with: 1) 
one 3% carbon dioxide and 13% oxygen tank; 2) one 
6% carbon dioxide and 17% oxygen tank; and 3) one 
0% carbon dioxide and 21% oxygen tank. Few labora­
tories nowadays are capable of performing Scholander 
analysis [172]; mass spectrometry is a reasonable "gold 
standard" measurement modality. A good practice is to 
maintain a single precision gas cylinder for occasional 
use; such a tank can last a number of years and (if reg­
ularly rotated to minimize settling effects) provide a 
long-term validation of calibration accuracy.
A third routine calibration must be performed in sys­
tems featuring breath-by-breath gas exchange measure­
ments. The transport delay between the gas sampling 
point and the gas analysers needs to be known with pre­
cision so that the respiratory airflow and gas concen­
tration signals can be properly time aligned. A solenoid 
allows an abrupt switch between two gas sources with 
different oxygen and carbon dioxide compositions and 
the time delay can be measured between the solenoid 
activation and the detection of change in gas analyser 
output. To this delay is added one time constant if the 
analyser response is exponential or the half time if the 
response is sigmoidal.
It is useful to perform an overall check of the venti­
lation and gas exchange measurements on a regular basis. 
One approach is to use a gas exchange simulator [173] 
that features a reciprocating piston; injection of a pre­
cision gas mixture at a precisely metered rate yields 
simulation of a known V'E, Vco2 and V'o2. Day-to-day 
variation of these calculations and the variation with 
changes in pump rate should be roughly in the range 
of ±3%. It should be noted that this gas exchange sim­
ulator does not simulate the moist exhalate at the expired 
temperature. Thus, assumptions about temperature and 
humidity corrections are not tested.
Other calibration procedures also need to be perform­
ed. Blood pressure transducers can be calibrated with 
a mercury manometer. Devices are available to calib­
rate electromagnetic ally braked cycle ergometers [174-
176]; calibration should be performed at least every 6 
months or whenever the cycle ergometer is moved (jar­
ring often disturbs the calibration) or when an unusual 
response profile raises concerns about the equipment. 
For treadmills, belt speed should be verified by timing 
revolutions of the belt with a subject on the treadmill; 
accuracy of the grade indication should also be vali­
dated [127]. There are two other quality control checks 
that are advisable. A healthy member of the laboratory
staff (with a consistent diet) should perform a constant 
work rate test at regular (perhaps weekly) intervals. 
Steady state values for V'02 differing by more than per­
haps 7% from previous values should engender a thor­
ough system-wide reassessment.
Finally, timed expired gas collections made during 
the steady state of exercise can be used as a "gold stan­
dard" to validate ventilation and gas exchange mea­
surements. Though laborious, when performed carefully, 
this method is generally accurate to within 2-3%.
Personnel and testing procedures
Personnel qualifications
Cardiopulmonary exercise testing should be conduc­
ted only by adequately trained personnel with a basic 
knowledge of exercise physiology. Technicians familiar 
with normal and abnormal responses during exercise 
and trained in cardiopulmonary resuscitation (CPR) 
should be present throughout the test. CPET should be 
performed under the supervision of a physician who is 
appropriately trained to conduct exercise tests and in 
advanced CPR. The degree of subject supervision need­
ed during the test can be determined by the clinical sta­
tus of the subject being tested and the type of exercise 
protocol. While it is preferable for the physician to be 
present during the test, if it is not possible, he/she must 
be readily available to respond as needed. Additional 
roles for the physician are the evaluation of the patient 
immediately before the test and the interpretation of the 
results.
Patient preparation
At the time of scheduling, the subject should be in­
structed to adhere to his/her usual medical regimen; he/ 
she should not eat for at least 2 h before the test, avoid 
cigarette smoking and caffeine, and dress appropriate­
ly for the exercise test. A brief history (with detailed 
inquiries about the medications) and physical exami­
nation should be taken to rule out contra-indications to 
testing. Results of recent resting pulmonary function 
tests (as a minimum forced spirometry) should be avail­
able for patients in whom pulmonary disease is sus­
pected.
On arrival at the CPET laboratory, a detailed explana­
tion of the testing procedure and equipment should be 
given to the patient, outlining risks and potential com­
plications as described below. The subject should be 
told how to perform the exercise test and the testing 
procedure should be demonstrated, if needed. The patient 
should be encouraged to ask questions to reduce any 
anxiety. The patient needs to become familiar with the 
equipment [91]. If the treadmill is used, time is pro­
vided for several practice trials of starting and stopping 
until the patient feels confident. If the cycle ergometer 
is used, the seat height is adjusted so that the subject's 
legs are almost completely extended when the pedals 
are at the lowest point and the cycling rhythm prac­
ticed .
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If arterial blood sampling is required, a catheter is in­
serted into a distal artery (preferably the radial or brachial 
artery) of the nondominant arm following proper pro­
cedures to ensure collateral circulation. Sterile techni­
que must be utilized during the catheter placement [148,
177]. A continuous flush device must provide a slow 
infusion of a heparinized saline solution. The dead space 
of the catheter used for sampling should be less than 1 
mL. To avoid spurious dilution, 2 mL of blood is dis­
carded before collecting each arterial blood sample.
Before the test, the ECG electrodes are carefully placed 
and secured after preparing the skin to ensure good 
recordings (if necessary, the area of the electrode place­
ment should be shaved). A sphygmomanometer cuff is 
placed on the upper arm. The mouth piece and nose clip 
are then tried and the position adjusted until a com­
fortable position is adopted. The patient is informed that 
it is acceptable to swallow with the mouth piece in place 
and that he/she must signal any unexpected difficulty 
by the signal "thumbs down". The patient is advised to 
point to the site of discomfort if chest or leg pain is 
experienced.
During the test, the patient is encouraged to carry on 
with a regular pedalling rhythm. Use of a metronome 
to assist in maintaining rhythm is often helpful. Symp­
toms and degree of discomfort are checked periodical­
ly (see safety precautions below). Good communication 
with the patient throughout the whole procedure incre­
ases the subject's confidence and predisposes to good 
effort.
During recovery, the patient is told to continue to 
pedal, without external workload (or walk at a slow pace 
on the treadmill), for at least 2 min during recovery in 
order to prevent fainting and to accelerate lactate remov­
al. At the point when the subject discontinues exercise, 
after removal of the mouthpiece, the physician should 
ask for symptoms (type and intensity) that prompted the 
patient to stop exercise. If blood gas analysis is perfor­
med, a last blood sample is taken after 2 min of recov­
ery.
If the test does not provide adequate diagnostic in­
formation because of premature termination or inade­
quate co-operation of the patient, it should be repeated 
after a resting period of 30-45 min.
After removal of the radial (or brachial) artery cathe­
ter, adequate pressure must be applied for sufficient time 
to avoid bleeding. This can take up to 10-15 min. A 
compression bandage should be applied to the site of
the puncture. The patient is advised not to remove the 
bandage and not to use his arm for heavy exercise with­
in 6 h after the test.
Safety precautions
Although CPET may be considered to be a safe pro­
cedure, risks and complications have been reported. A 
recent review [160] summarizing eight studies of esti­
mates of sudden cardiac deaths during exercise testing 
revealed rates from none (four studies) to five per 100,000 
tests. A French study [178] based on 458,000 exercise 
tests (1975-1985) reported one death per 76,000 exer­
cise tests. However, the relative risk of an adverse event 
is strongly related to the underlying disease, particularly 
in subjects post-myocardial infarction or with malignant 
arrhythmias. Good clinical judgement should be para­
mount in defining indications and contra-indications for 
exercise testing [159]. Table 4 lists absolute and rela­
tive contra-indications to CPET. Cardiac (bradyarrhyth­
mias, ventricular tachycardia, myocardial infarction, heart 
failure, hypotension and shock) and noncardiac (mus­
culoskeletal trauma, severe fatigue, dizziness, fainting, 
body aches) complications of CPET have been repor­
ted. Consequently, during the test, the personnel should 
be alert to any abnormal event.
Indications to stop the test must be clearly established 
and known by all the personnel involved in testing. 
These indications include symptoms such as: 1) acute 
chest pain; 2) sudden pallor; 3) loss of co-ordination; 4) 
mental confusion; and 5) extreme dyspnoea. The signs 
include: 1) depression of ST segment greater than 0.1 
mV (less specific in females); 2) T-wave inversion; 3) 
sustained ventricular tachycardia; and 4) fall in systolic 
pressure either below the resting value or about 20 
mmHg below its highest value during exercise testing. 
Relative indications to stop the test are: 1) polymorphic 
and/or frequent premature ventricular beats; and 2) hy­
pertension (>250 mmHg systolic; >130 mmHg dias­
tolic). If the exercise test has been stopped for one of 
these reasons, the patient should be monitored in the 
CPET laboratory until symptoms or ECG modifications 
have completely cleared. Admission to hospital for longer 
observation or more often for complementary investi­
gation will be necessary in very rare cases. If neces­
sary, intensive care can be administered on site. Full 
CPR equipment should be available in the CPET labo­
ratory .
Table 4. -  Contra-indications for cardiopulmonary exercise testing
Absolute Relative
Acute myocardial infarction (3-5 days)
Unstable angina
Uncontrolled arrhythmias causing symptoms or haemodynamic
compromise
Active endocarditis
Acute myocarditis or pericarditis
Symptomatic severe aortic stenosis
Uncontrolled heart failure
Acute pulmonary embolus or pulmonary infarction 
Acute noncardiac disorder that may affect exercise performance or 
be aggravated by exercise (i.e. infection, renal failure, thyrotoxicosis) 
Thrombosis of lower extremities
Left main coronary stenosis or its equivalent 
Moderate stenotic valvular heart disease 
Electrolyte abnormalities
Severe untreated arterial hypertension (>200 mmHg 
systolic, >120 mmHg diastolic)
Significant pulmonary hypertension 
Tachyarrhythmias or bradyarrhythmias 
Hypertrophic cardiomyopathy 
Mental impairment leading to inability to cooperate 
High-degree of atrioventricular block
"Relative" contra-indications can be over-ruled if the benefits outweigh the risks of exercise.
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Interpretative strategies
As mentioned above, the main general goal of CPET 
is to evaluate the degree of limitation of exercise tol­
erance and to identify its causal factors. Optimal clin­
ical application of CPET should be attained by properly 
accomplishing each of the steps indicated in figure 1:
1) identify the clinical problem for which CPET is 
required; 2) choose the exercise protocol; 3) ensure high 
quality results; 4) present results using a proper format;
5) select adequate reference values to establish patterns 
of abnormal response; and 6) compare with character­
istic patterns of certain diseases.
In this section on interpretation of clinically orient­
ed CPET, we first recommend a logical strategy to 
approach the problem. Comparative analysis of differ­
ent sets of available reference values is also provided 
and, finally, detailed information on the variables indi­
cated in table 5 (definition, information content, units 
and calculations) is described in the Appendix.
General guidelines
Several points should be considered in the interpre­
tation of CPET results. First, suggestions in the litera­
ture supporting interpretative strategies based on single 
key measurements to direct the flow-chart decision did 
not prove to be adequate. The greatest diagnostic poten­
tial and impact on the clinical decision making process










Vo2, Vco2, RER, LT 
V'E, VT,/, VR
Pa,02, Pa,C02, DA-a,02, VD/VT, 5a,02 
/C, HRR, Pa,sys, ECG, 0 2 pulse 
pHa, Pa,co2, base excess or 
standard C03H~ concentration 
Dyspnoea, leg pain, chest pain
Basic plots
V'C02 (ordinate) vs V o2 (abscissa)
Ve/V'co2 (ordinate) and V'e/V'o2 (ordinate) vs V o2 (abscissa)
Pet,co2 (ordinate) and Pet,o2 (ordinate) vs V o2 (abscissa)
RER (ordinate) vs V o2 (abscissa)
V o2 (ordinate) vs work rate (abscissa)
V e (ordinate) vs V'co2 (abscissa) or Ve (ordinate) vs V o 2 
(abscissa)
fc (ordinate) and Vco2//c (ordinate) vs V o2 (abscissa)
Vt (ordinate) vs V’E (abscissa)
Examples of the basic plots are shown in figure 7. Vo2: oxy­
gen consumption; V co2: carbon dioxide production; RER: 
respiratory exchange ratio; LT: lactate threshold; VR: venti­
latory reserve; ƒ: frequency; Pa,02: arterial oxygen tension; 
DA-a,o2: alveolar-arterial oxygen difference; Vd: dead space 
volume; Vt: tidal volume; Sn,o2: arterial oxygen saturation; 
fc: cardiac frequency; HRR: heart rate reserve; Pa,sys; sys­
temic arterial pressure; ECG: electrocardiogram; pHa: arterial 
pH; Pa,co2: arterial carbon dioxide tension; V'E: minute ven­
tilation; P e t ,c o 2: end tidal partial pressure of C 02; P e t ,o 2: 
end tidal partial pressure of 0 2.
should rely not on the utility of any one individual mea­
surement, although some are obviously more important 
than others, but rather on their integrated use [1], Con­
sequently, a key point is the identification of a cluster 
of responses characteristic of different diseases.
The major portion of the interpretation strategy is 
focused on CPET results generated during maximal, 
symptom-limited, incremental exercise testing. This is 
currently the most popular, albeit not exclusive, proto­
col. Often, insufficient attention is paid to trending phe­
nomena as the work rate progresses from submaximal 
to peak levels. To facilitate this type of analysis, the 
results should be formatted in an appropriate manner. 
While various display formats can be helpful in this re­
gard (see [2] for example), one suggested format is pre­
sented in figure 7, which displays data obtained in a 
normal subject performing cycle ergometry, using an 
ergometer that utilizes an "assist" to provide an actual
0 W work rate at "unloaded" pedalling. Figures 7a-d 
provide, in addition to the peak Vo2, the variables com­
monly used to provide an indirect estimation of the LT 
(as described in the Appendix using a cluster of rele­
vant responses for the estimation, rather than relying 
on a single index). That is, the Vo2 at which the tran­
sition between moderate and heavy-intensity exercise 
occurs is identified. Figure 7e (Vo2 versus work rate) 
reflects the exercise efficiency (see section on Response 
to exercise in lung disease, subsection on Pulmonary 
gas exchange) and the limits of exercise tolerance of 
the subject. Figure 7f (ventilation versus V'C02) and fig' 
ure 7h (VT versus ventilation) characterize aspects of 
the ventilatory response during submaximal and maxi- 
mal exercise. However, some investigators find the rela­
tionship between Ve and Vo2 during such tests to be 
useful. Finally, figure 7g is informative with respect to 
the characteristics of the haemodynamic response to 
exercise. The next step is to choose adequate reference 
values to establish patterns of normal or abnormal res­
ponse. Available data on reference values and present 
limitations in this particular issue are discussed below. 
This graphical analysis (fig, 7) can be even more illus­
trative of the subject's exercise performance if the cor­
responding reference values are also displayed in each 
plot (see [2] for example). A proper interpretation of 
CPET results should rely on both numerical analysis 
of the variables of interest (table 5) and assessment of 
trending phenomena throughout the exercise test using 
the graphical analysis suggested above. Comprehensive 
CPET can provide extremely useful information in the 
judgement on the system's tolerance to exercise by help­
ing to answer the following basic questions in a given 
patient: 1) to what extent is the system constrained or 
limited? 2) how is it perceived? 3) are the metabolic 
requirements for a given task met? and 4) what is the 
cost of meeting the requirements?
The final step in this approach to the interpretation 
of CPET results is to identify clusters of responses cha­
racteristic of different diseases. It should be pointed out 
that each step of the proposed interpretative strategy is 
important; unless a flow-chart logic (e.g. [2]) is fol­
lowed, the analysis of CPET results is prone to misin­
terpretations. Different algorithms to guide the decision 
making process, in discriminating a range of function­
al abnormalities, have been reported [1, 2 , 87] and are
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Fig. 7. - Basic plots recommended for the interpretation of CPET. Figures a-d, in addition to peak V 02, provide the variables commonly used 
to indirectly estimate the LT (as described in the appendix). That is, the at which the transition between moderate and heavy-intensity exer-
legend to table 5.
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available in the literature. The logical flow commonly 
begins with the judgement of whether exercise toler­
ance was normal or not. If the subject shows abnorm­
al limitation to exercise, the next logical step might be 
the analysis of the submaximal exercise region in order 
to identify the LT. If the physiological changes indi­
cating the transition from moderate to heavy-intensity 
exercise occur within the lower end of the expected 
range of V'02 for a normal subject (but within it), then 
the dilemma is whether the subject had voluntarily 
stopped the test early or whether a physiological limi­
tation to exercise performance can be identified. For 
example, were the analysis of the ventilatory function 
to show that the ventilatory reserve (VR; see Appen­
dix) was zero or low but the heart rate reserve (HRR) 
was high at the end of the test, this suggests that the 
patient probably had a ventilatory limitation to the exer­
cise, rather than stopping deliberately or as a result of 
acute discomfort, such as that of angina.
The above recommended guidelines for CPET inter­
pretation propose a general logic framework for the ana­
lysis of limitation of exercise tolerance, e,g: cardiovascular 
(heart, systemic circulation and blood); respiratory (ven­
tilation, pulmonary circulation and gas exchange); and 
peripheral muscle factors (neuromuscular-related ab­
normalities, impairment of muscle micro vasculature, ab­
normal cellular oxygen or other substrate utilization). 
However, additional factors, such as psychogenic ones, 
can also be limiting. However, results of CPET, like 
other physiological tests in cardiopulmonary medicine, 
demonstrate patterns of abnormality with overlap bet­
ween the responses of patients with different disorders. 
Table 6 provides a description of the most characteris­
tic features of abnormal responses in different patient 
categories. In each of these categories there is one or 
more variables that have a predominant role in deter­
mining the severity of impairment. An expanded and 
detailed description of these patterns of abnormality can 
be found in elsewhere [85] .
Relatively few studies have evaluated the sensitivity, 
specificity and predictive value of patterns of measure­
ments in distinguishing different clinical entities. Even 
more importantly, the precise role of clusters of vari­
ables commonly used in the decision making process in
well identified diseases (i.e., evaluation of ILD, preop­
erative evaluation for resectional lung cancer surgery, 
etc.) is insufficiently known. For the future, studies ad­
dressing the use of likelihood ratios [179] might be even 
more useful to clinicians than sensitivity and specifi­
city, since likelihood ratios refer to actual test results 
before disease status is known. This shift to an evidence- 
based approach [180] for CPET interpretation will, hope­
fully, provide important answers to clinically relevant 
questions that are not immediately available,
Reference values
As indicated above, selection of appropriate reference 
values is an important step to establish patterns of nor­
mal or abnormal response to exercise stress. An initial 
analysis of available data on healthy subjects [1, 2, 12,
118, 181-191] clearly indicated that only five of these 
studies [2,181,184-186] fulfill minimum requirements 
to be considered as candidates to be used in the clinical 
setting [85]. However, Blackie et ah [184] cover a lim­
ited age span (55-80 yrs), and Bruce et al. [186] pro­
vide data obtained with treadmill in a population of 
physically fit people. Hence, the analysis of potential 
studies in healthy sedentary people providing predic­
tion equations for peak V'02 obtained with incremental 
cycling exercise testing is reduced to three sets [12,181, 
185], Basic characteristics of these three studies are summ­
arized in table 7. Reference values estimated by Fairbarn 
et al. [185] are consistently higher than those provided 
by Jones et al, [181]], both in men and women. The 
predicted values of Hansen et al. [2, 12] are closer to 
either Jones et al, [181] or Fairbarn et al. [185] depend­
ing upon the values of height-weight of the subject in 
whom the equations are used. The limitations of the 
presently available prediction equations for peak Vo2 
(and peak work rate) clearly impose limitations on the 
interpretative strategy. Moreover, except for fc  in the 
study of Fairbarn et al. [185], the profile of response 
in healthy sedentary subjects (i.e., from submaximal to 
peak exercise results) are not available. Furthermore, 
adequate prediction equations for even the most impor­
tant variables (i.e., these indicated in table 5) obtained
Table 6. Patterns of abnormal response to exercise in different diseases
COPD ILD PVD Obesity Deconditioned Heart failure








Low Low Normal or low Low









Normal N ormal Normal Reduced 
or normal
0 2 pulse at peak exercise Reduced Reduced Reduced Normal Reduced Reduced
Fall in Sa,02 at peak exercise Present 
or absent
Present Present Absent Absent Absent
COPD: chronic obstructive pulmonary disease; ILD; interstitial lung disease; PVD: pulmonary vascular obstructive disease; Vo2,peak: 
oxygen uptake at peak exercise; LT: lactate threshold; Ve,reserve: see Appendix; HRR: heart rate reserve (see Appendix); 0 2 
pulse: V o2,peak/peak cardiac frequency; Sa,o2: oxyhaemoglobin saturation in arterial blood.
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Table 7. -  Characteristics of the main sets of prediction equations
First author [ref] Gender Equations Population Subjects Equipment
Hansen [2, 12] M V o 2 ,peak (mL-mhr1) (50.75 - 0.372A)Wt 77M Shipyard Cycloergometer
F V o2,peak (mL-mnr1) (22.78 - 0.17A)(Wt+43) Age 34-74 yrs workers Breath-by-breath
10-30 W increments
Jones [181]* M V'o2,peak (L-min'1) 0.046H - 0.021A - 4.31 50M/50F V olunteers Cycloergometer
F V,02)Peak (L-min-1) 0.046H - 0.021A - 4.93 Age 15-71 yrs 10 L mixing box
M WR (kpnvmiir1) 204H - 8.74A - 1909 100 kpm-mnr1
F WR (kprrvmin-1) 20.4H - 8.74A - 2197 increments
Blackie [184] M V o2,Peak (L-min-1) 0.0142H - 0.0494A 47M/8 IF Volunteers Cycloergometer
+ 0.00257Wt + 3.015 Age >55 yrs 10 L mixing box
F V'02,Peak (L-min-1) 0.0142H - 0.0115A 100 kpnvmnr1
+ 0.00974Wt + 0.651 increments
M WR (kprn-mhr1) 6.1H - 26.1A + 0.04Wt + 1.704
F WR (kpm-min'1) 74H - 13.0A 4- 3.78Wt + 52
Fairbarn [185] M V o2,peak (L-min-1) 0.023H - 0.031 A 111M/120F Volunteers Cycloergometer
+ 0.0117Wt- 0.332 Age 20-80 yrs 8.5 L mixing box
F V'o2,peak (L-min-1) 0.0158H - 0.027A 100 kpm*min-1
+ 0.00899Wt + 0.207 increments
M: male; F; female; A: age in years; H: height in centimetres; Wt: weight in kilograms; WR: work rate; kprn: kilopondmeters. 
For further definitions see legend to table 6. Hansen et al. [2, 12] suggest alternative equations for those subjects with differ­
ences between actual and ideal body weight. *: equations simplified from, Jones et al. [181] provide prediction equations for 
cardiac frequency and 0 2 pulse at peak exercise; Fairbarn et al. [185] provide equations for cardiac frequency during submaxi- 
mal and peak exercise.







Name Units Name Units Sl/traditional
Mechanical work




V'Ot mL-min-1 n'o2 mmol-min-1 22.40-1
V'C02 mL-miir1 ïî co2 mmol’min-1 22.46-1
RER RER 1.0
Ventilation
V'E L-min-1 V'E L-min-1 1.0
Vr mL or L Vt mL or L 1.0




Pa,02 mmHg Pa,02 kPa 0.133
Pa,C02 mmHg Pa,C02 kPa 0.133
DA-a,02 mmHg DA-a,02 kPa 0.133
Vd/Vt - VüfVr at* 1.0
Cardiovascular
/c beats-miir1 f i beats'mhr1 1.0
HRR - HRR 1.0












goal in this area is to stimulate a multi­
centre study, with the aim of generating 
an appropriate set of reference values. This 
would establish both the magnitude and 
profiles of response of the essential CEPT 
variables utilizing standardized procedures 
and rigorous quality control (within and 
among participating laboratories). Addition­
al potential gains from such a programme 
would be the comparison among incre­
mental cycling, incremental treadmill and 
constant work load exercise testing in a 
subset of subjects. Such a project would 
provide a major advance in r 




For definition of abbreviations see legend to table 5. n'o2, n'C02: millimoles per 
minute of oxygen and carbon dioxide, respectively; kpm: kilopondmeters; Con­
version factor; Traditional unit to SI unit (SI/traditional unit).
from the same group of reference subjects are not cur­
rently available. The absence of appropriate reference 
values can naturally lead to miscategorization and pos­
sible misinterpretation of the results.
The Task Force members consider that an important
SI stands for "Système International 
d'Unités" [192, 193]. These units are the
result of over a century of international 
co-operation to develop a universally ac­
ceptable system of units of measurement. 
The SI is an outgrowth of the metric sys­
tem that is being increasingly used all over 
the world, but which has had rather little 
impact in the United States of America 
(USA), even though Congress passed the 
Metric Conversion Act in 1975, which 
endorsed the SI scale. Formally, the SI units were adop­
ted by all the members of the European Union about 
20 yrs ago. Table 8 indicates both nomenclature and 
conversion factors of the SI units for the variables used 
in the present document.
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Variables: definitions and calculations
Mechanical work. Work rate (W). This indicates the 
amount of work performed per unit of time. Work (kg- 
m2,s~2, J), in turn, is a physical quantification of the 
force (kg*m2'S‘2, N) operating on a mass (kg) that caus­
es its change of position (distance expressed in meters). 
The work rate (or power) is measured in watts (kg’m2- 
S‘3 or J’S“1)’
Gas exchange. Oxygen uptake (Vo2, in mL-min-1 or 
L-min-1). Is the difference in oxygen flow between in­
spired and expired gas (in STPD conditions, see below). 
During steady-state conditions, oxygen uptake and con­
sumption (amount used by the body metabolism in a 
given period of time) are equivalent. V'o2 may be cal­
culated as:
Vo2 = V'vFl,02 - VFE’FE,02
or, if only Ve is determined:
Vo,=
/ Fe ,n2 v 
(F i ,02- ( — — )  - F e ,o 2)-V'e
Fijsu
where V'E is expiratory minute ventilation and Vi is 
inspiratory minute ventilation, Fi,02 and Fe,02 are the 
fractional concentrations of inspired oxygen and expir­
ed oxygen, and Fi,N2 and Fe,N2 are the fractional con­
centrations of inspired and expired nitrogen.
Carbon dioxide output (Vco2 mL-min"1)* In the absence 
of inspired carbon dioxide, V'C02 is the flow of carbon 
dioxide exhaled from the body into the atmosphere, ex­
pressed in STPD conditions (see below). During steady 
state conditions, carbon dioxide output equals produc­
tion by the body. Calculation of Vco2 can be comput­
ed as the total volume of carbon dioxide exhaled in a 
given period of time:
Vco2 = Fe,c o2*Ve
where Fe ,C02 is the fractional concentration of expir­
ed carbon dioxide.
Respiratory exchange ratio (RER or R, dimensionless). 
This is the ratio of V'C02 to Vo2. RER reflects not only 
tissue metabolic activity, but also the influence of trans­
ient changes in body stores of respiratory gases (oxygen 
and, most importantly, carbon dioxide). The respirato­
ry quotient (RQ) is the ratio of V'C02 to Vo2 and reflects 
the metabolic substrate utilization. During hyperven­
tilation, RER exceeds RQ because additional carbon 
dioxide from the body stores is exhaled, whereas the 
RER is less than the RQ during transient hypoventila­
tion when carbon dioxide is retained in the body stores.
Lactate threshold (LT, mL'rnhr1), This is the exercise 
V'o2 above which a net increase in lactate production 
results in a sustained increase in blood lactate concen­
tration. The LT provides: 1) an index of the functional 
status of the respiratory-circulatory-metabolic integra­
tion that allows exercise to be sustained aerobically; 2) 
an index of sustainability for that particular task; 3) a 
frame of reference for optimizing training protocols and 
monitoring physical training, rehabilitation and drug in­
terventions; and 4) a component of decision-making stra­
tegies for elucidating the dominant system(s) responsi­
ble for exertional dyspnoea, and exercise intolerance. 
Its limitations, however, in patients with lung disease 
have been indicated in the text and are further analysed 
below:
1) Direct measurements of LT. The response profile of 
arterial lactate concentration versus Vo2 is often not the 
most sensitive estimator for LT, as there may be no 
clear "break-point" in the profile that can be identified 
with sufficient confidence (for some investigators, at 
least).
2) Arterial lactate-pyruvate concentration ratio. As a 
component of the arterial lactate concentration, incre­
ase reflects pyruvate-dependent increase, as a result of 
increased glycolytic flux; the ratio of arterial lactate to 
pyruvate concentrations provides a clearer manifesta­
tion of the threshold behaviour,
3) Logarithmic arterial lactate and bicarbonate concen­
tration functions. This approach transforms the arterial 
lactate concentration (or arterial standard bicarbonate 
concentration, standard ([HC03\])) response to a loga­
rithmic function. This provides an even clearer discri­
mination of the lower (i.e, subthreshold) and higher (i.e. 
suprathreshold) regions of the response. It typically lin­
earizes the more sharply rising phase of the response, 
intersecting the lower phase of the response, which com­
monly displays a small positive slope. It is important, 
however, that the appropriate sampling site is used for 
determining LT. Arterial (or mixed venous, in some 
instances) blood is most appropriate. Properly "arteria- 
lized" venous blood is acceptable.
Noninvasive estimators of LT (ventilatory equivalent 
method and V-slope method) [194, 195] are described 
below. As indicated previously (see section on Equip­
ment and quality control programme), the discriminability 
of LT can be enhanced in some cases by utilizing a par­
ticular cluster of ventilatory and pulmonary gas exchange 
responses.
Ventilatory equivalent method. The compensatory hy­
perventilation for the metabolic acidosis of heavy and 
severe exercise typically coincides with the increase in 
arterial lactate concentration and the decrease in arter­
ial standard [HC03~]. As a test for this, the work rate 
is incremented in a quasi-steady state manner (i.e. incre­
ment duration of 3-4 min or more); V'E begins to increase 
more rapidly than V'C02 and Vo2 (i.e. the ventilatory 
equivalents for oxygen and carbon dioxide (Ve/Vo2, VeI 
Vco2) both increase and P&,C02 is, therefore, reduced.
In contrast, however, when the work rate incremen­
tation rate is more rapid, the compensatory hyperventi­
lation is strikingly attenuated. In this situation, there is 
a range of work rates immediately above LT within 
which V'E and V'co2 increase in approximately the same 
proportionality as for moderate exercise; i.e. Ve/Vco2 
does not increase. Under these conditions, Vco2 has 
contributions both from metabolic sources and from bi­
carbonate buffering reactions. Therefore, as Pa,c02 does 
not fall in this region, it has been termed the range of
1,isocapnic buffering". However, the additional Ve that 
clears this augmented load of carbon dioxide is, there­
fore, out of proportion to V'o2 causing V,e/Vo2 to in­
crease. Respiratory compensation for the lactic acidosis
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(i.e. with Pa,CO2 actually decreasing) only begins for 
rapid incremental tests at a work rate which is typica­
lly about midway between LT and V'02,max. This has 
been termed the "respiratory compensation point". It is, 
therefore, important to recognize that the respiratory 
compensation point is a function of the incrementation 
rate of the test, whereas LT is not.
The phenomenon of isocapnic buffering consequent­
ly helps rule out nonspecific hyperventilation (such as 
is seen in some excitable subjects and also in patients 
with McArdle's syndrome) as a "false positive" lactate 
threshold. For an appropriate rapid incremental exer­
cise protocol, LT has typically been taken as the V'o2 
(not the work rate) at which the alveolar (end-tidal) Po2 
(Pet,02) and the ventilatory equivalent for oxygen (V'E/ 
Vo2) start to rise systemically without a simultaneous
fall in Pet,co2.
Some individuals (such as those with intensive periph­
eral chemoreceptors or those with appreciably increa­
sed airways resistance), may have a compromised ability 
to generate the required increases in V'E at higher work 
rates. As a result, if there is no, or possibly little, addition­
al ventilatory response, it proves difficult, or impossible, 
to discriminate LT according to these ventilatory-related 
criteria. The V-slope approach was developed to over­
come this challenge to discrimination.
The V-slope method. With this procedure, LT is iden­
tified from the relationship between V'C02 and V'02. The 
acceleration of the rate of increase in V'C02 relative to 
V'02 above the LT provides evidence for an increased, 
but still essentially linear, slope (S2, fig- 8), within the 
isocapnic buffering phase. The intersection of the two 
linear phases (Sj and S2, fig. 8) has been shown to agree 
closely with the beginning of the increase in arterial lac­
tate concentration and arterial lactate/pyruvate concen­
tration ratio and even more closely with the decrease 
in arterial standard [C03H-], i.e. a small amount of the 
initial increase in muscle lactate is buffered by nonbi­
carbonate buffers [2, 147], and hence does not yield 
increased V'C02. The consequence for LT discrimina­
tion, however, is likely to be disappearingly small dur­










0 1 2 3
V'o2 L-minin “1
Fig. 8. - Estimation of lactate threshold (LT) using the V-slope 
method (see text for further explanations). The intersection of the 
slopes of the two linear phases (Si and S2) corresponds to the LT, 
For definitions, see legend to table 5.
Sj and S2 regions are perceived not to be sufficiently 
linear for the intersection to be meaningful, it has been 
proposed that the point on the curve at which a line of 
slope 1.0 is tangential will provide an adequate approx­
imation of the threshold [196].
Ventilation, Minute ventilation L-min-1. Volume of gas 
expired (V'E) or inspired (V'l) in one minute, expressed 
in BTPS conditions (see below).
Tidal volume (Vr, mL or L). Volume of gas inspired 
(or expired) during each breathing cycle. It is comput­
ed as the ratio of minute ventilation (L'mhr1) to respi­
ratory frequency (breaths-mur1).
Respiratory frequency (/R, in breaths-min”1). Number of 
breathing cycles per minute. It is computed as the ratio 
60 divided by the total time of the breathing cycle (s).
Ventilatory reserve (VR, dimensionless). Difference bet­
ween ventilatory capacity during maximum exercise (es­
timated as maximum voluntary ventilation (M W )) and 
minute ventilation at peak exercise, expressed as a per­
centage of M W . It is computed as:
VR % = ((M W  - peak V'e)/MVV>100
It, thus, represents the potential for further increase in 
ventilation during maximal (or peak) exercise.
Respiratory blood gases. Arterial Po2 (Pa,02, mmHg). 
Oxygen partial pressure in arterial blood.
Arterial PC02 (Pa,C02 mmHg), Carbon dioxide partial 
pressure in arterial blood.
Alveolar-arterial oxygen difference (DA-a,o2, mmHg). 
Difference between ideal alveolar partial pressure of 
oxygen (Pa,o2) and measured Pa,o2. The DA-a,o2 is com­
puted using the alveolar gas equation described in the 
opening section:
DA-a,02 = (Pl,02 - Pa,C02/RER + 
(Pa,C02-Pr,02*(1 -RER)/RER) - Pa,02
where RER is the respiratory exchange ratio (RER= 
V'C02/V'02). This equation is derived from mass balance 
considerations of oxygen and carbon dioxide exchange 
between the air and the alveolar gas and assumes con­
stancy of lung nitrogen stores. Thus, even if oxygen, 
carbon dioxide and V'E are changing, the DA-a,02 can 
be validly computed if there is nitrogen balance between 
inspiration and expiration. It is important to recognize 
that the absolute blood gas values and the DA-a,o2 yield 
different, but complementary information. The DA-a,02 
primarily reflects pulmonary defects in gas exchange 
caused by V'a/Q' mismatching, diffusion limitation and 
shunt, either alone or in combination. It can, however, 
be modified by changes in cardiac output or ventilation 
even in the absence of change in V'a/Q' distribution.
Dead space to tidal volume ratio (Vd/Vt dimension- 
less). Portion of tidal volume (Vt) ventilating physio­
logic dead space (VD). It is an index of the efficiency
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of the lung as carbon dioxide exchanger. It is compu­
ted as the ratio of the difference between Pa,C02 and 
mixed expired Pco2 (Pa,C02 - Pe,C02) to Pa,co2:
VD/VT % = ((jPafC02- PE,CO2)/Pa,CO2>100
Cardiovascular. Cardiac frequency (/C, beats’miir1). Num­
ber of cardiac beats per minute. It is computed as the 
ratio of number of complete beats during 1 min to the 
total time of the cardiac cycle.
Heart rate reserve (HRR, dimensionless). Ratio of the 
difference between the predicted highest cardiac fre­
quency at maximum exercise and the measured peak 
cardiac frequency to the predicted highest cardiac fre­
quency at maximum exercise, expressed as a percent­
age.
HRR = ((Predicted maximum fc  - peak fc)/
predicted maximum /C)* 100
0 2 pulse (V'Ojft:, mL). Corresponds to the amount of 
oxygen uptake per cardiac cycle. The 0 2 pulse is num­
erically equal to the product of the stroke volume and 
the arterial-to-venous oxygen content difference. Con­
sequently, inferences which are drawn about one of the 
contributory variables are highly dependent on assump­
tions regarding the response of the other(s).
Acid-base status. Arterial pH (pHa). Inverse of the dec­
imal logarithm of the arterial blood hydrogen ion con­
centration ([H+]), It indicates the global acid-base status 
(respiratory and metabolic components) of the arterial 
blood.
Pa,C02 (described above). Reflects the contribution of 
the respiratory component to the acid-base status .
Base excess (BE, mEq-L1)- Indicates the contribution
of the metabolic component (nonvolatile substances) to 
the acid-base status of the blood. The BE is computed 
using the Henderson-Hasselbach equation with mea­
sured values of pHa and Pa,C02. Haemoglobin concen­
tration and oxyhaemoglobin saturation influence the BE 
calculation by modulating the buffer capacity of the 
blood. The information provided by this variable is sim­
ilar to that obtained estimating the standard [~C03H].
Measurement conditions. STPD. Gas volume measure­
ments at standard conditions of temperature (0°C) and 
pressure (760 mmHg (101.3 kPa)), free of water vapour 
(partial pressure of water vapour Ph2o = 0 kPa).
BTPS. Gas volume measurements at body temperature 
(37DC), ambient atmospheric pressure and saturated with 
water vapour at body temperature (Ph2o = 47 mmHg
(6.2 kPa)).
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